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ABSTRACT 
Angelman syndrome (AS), chromosome 15q11-q13 duplication syndrome (Dup15q), 
and Prader-Willi syndrome (PWS) are neurodevelopmental disorders associated with 
dysregulated expression of imprinted genes located within the human 15q11-13 
imprinted region.  Angelman syndrome is caused by loss-of-function or loss-of-
expression of the maternally inherited UBE3A allele; Dup15q syndrome is attributed to 
maternally inherited copy number gains of UBE3A; and, paternally inherited deletions of 
the SNORD116 cluster cause PWS. The UBE3A gene is imprinted in the brain with 
maternal-specific expression and biallelically expressed in all other cell types. The 
imprint is regulated by expression of the UBE3A antisense transcript (UBE3A-AS), 
which is expressed only in neurons and imprinted with paternal-specific expression. The 
UBE3A-AS represents the 3` end of a long polycistronic transcript that includes the 
SNORD116 and SNORD115 gene clusters. Thus, the genes causing AS, Dup15q, and 
PWS are transcriptionally linked; however, the functional significance of the neuron 
specific imprint is largely unknown.   In this dissertation, it was hypothesized that 
imprinting of UBE3A evolved as a mechanism to negatively regulate UBE3A protein 
levels in neurons.   This hypothesis was tested by examining allelic expression patterns 
and associated protein levels of the mouse 7c imprinted region, the orthologous region of 
human 15q11-q13. 
Analyses revealed that imprinted expression of Ube3a in the brain resulted in elevated 
RNA and protein levels compared to tissues where Ube3a was biallelically expressed.  
iii 
Likewise, Snord116, Snord115, and Ube3a-AS transcripts were highly expressed in the 
brain.  The elevated Ube3a protein levels in the brain were due to increased maternal-
allelic expression during neurogenesis concurrent with paternal-allelic suppression. 
Analysis of UBE3A expression in the opossum, a metatherian mammal lacking an 
orthologous imprinted region, showed that the UBE3A imprint did not evolve to 
negatively regulate UBE3A protein levels in the brain. Extensive alternative splicing of 
Ube3a-AS was detected in the brain, which generated at least two transcripts containing 
novel open reading frames.  Novel Ube3a alternatively spliced transcripts were also 
identified in the brain.  Collectively, these data reject the hypothesis that the UBE3A 
imprint evolved to negatively regulate UBE3A protein levels in the brain; instead, they 
suggest that the UBE3A imprint may allow co-expression of the UBE3A and SNORD 
gene cluster in neurons, which may also facilitate or regulate the expression of novel 
brain-specific UBE3A transcripts.   
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1. INTRODUCTION
Genomic imprinting is an epigenetic phenomenon that results in the differential 
expression of diploid alleles in a parent of origin specific manner [1]. Imprinted genes 
are functionally hemizygous, often dosage sensitive and responsible for various 
pathological states when their expression patterns are dysregulated [2, 3].  Genomic 
imprinting only occurs in therian mammals and flowering plants [4, 5].  It has also been 
observed in some insects, but it’s unclear whether this phenomenon is a true form of 
genomic imprinting [6].  Numerous theories exist to explain the evolution and function 
of imprinted genes (e.g., conflict, host-defense, maternal time-bomb, and developmental 
plasticity hypotheses [see 2.1.6]); however, there is currently no unifying theory that is 
applicable to all, much less most, imprinted genes  [7].   Overall, the functional 
significance of imprinting is largely unknown and seemingly contradictory to the 
presumed evolutionary advantage of diploidy [8]. 
The human 15q11-q13 region contains a cluster of conserved imprinted genes that 
evolved approximately 110 million years ago (Figure 1) [9, 10].  Most of the genes in 
this region are exclusively expressed from the paternal chromosome in the tissues in 
which they are transcribed.  The imprinted genes in 15q11-q13 with paternal-specific 
expression include: small nucleolar ribonucleoprotein polypeptide N (SNRPN), SNRPN 
upstream reading frame (SNURF), necdin (NDN), mage-like 2 (MAGEL2), makorin 3 
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Figure 1.  The 15q11-q13 imprinted region.  Genomic imprinting of genes in 15q11-q13 is regulated by 
a partite imprinting center comprised of the two imprinting control elements: the Angelman syndrome 
imprinting control element (AS-ICE) and Prader-Willi syndrome imprinting control element (PWS-ICE).  
The AS-ICE is methylated and inactivated in sperm (filled diamond lollipops), whereas the maternal-allele 
is shielded from methylation by a bound germline protein complex (open diamond lollipops).  
Subsequently, the maternal AS-ICE negatively regulates the maternal PWS-ICE (red arrow) leading to its 
methylation (filled circle lollipops).  The unmethylated paternal PWS-ICE (open circle lollipops) 
positively regulates (green arrows) the flanking paternally expressed genes (blue boxes) by an unknown 
mechanism.  The PWS-ICE overlaps the SNURF-SNRPN promoter, which utilizes alternative upstream 
exons of SNRPN to gives rise to a long RNA transcript containing the SNORD116, SNORD115, IPW, and 
the UBE3A-AS.  Expression of the UBE3A-AS overlaps the paternal UBE3A allele, which acts in cis to 
inhibit paternal-allelic expression by some unknown mechanism.  Expression of the maternal allele (pink 
box) is unaffected by the UBE3A-AS. Figure legend: gray boxes indicate the inactive allele; black boxes 
indicate biallelically expressed genes; arrows indicate the direction of transcription (5’  3’).  
Abbreviations: M = maternal allele; P = paternal allele.  Schematic is not drawn to scale. 
 
(MKRN3), nuclear pore associated protein 1 (NPAP1) genes, Prader-Willi region non-
protein coding RNA 1 (PWRN1), and two C/D box small nucleolar RNA (snoRNA) 
clusters (SNORD115 and SNORD116) [11, 12].  At the distal end of the region lies the 
ubiquitin protein ligase E3A (UBE3A) gene [13].  Unlike the other imprinted genes in 
the region, UBE3A is imprinted with maternal-specific expression in the brain and 
biallelically expressed in all other cell types [14-17].  Also unique to UBE3A is the 
presence of active post-translational histone modifications and RNA polymerase II at the 
inactive paternal allele in the brain [18, 19].  Consequently, the paternal allele 
3 
transcribes a 5` truncated transcript, but the function, if any, of this transcript is unknown 
[18, 20].  
Genomic imprinting of the genes in 15q11-13 is controlled by the Prader-Willi and 
Angelman syndrome imprinting control elements (PWS-ICE and AS-ICE [Figure 1]) 
[21, 22].  On the maternal chromosome, the AS-ICE acts in cis to negatively regulate the 
activity of the adjacent PWS-ICE [23, 24].  On the paternal chromosome, the AS-ICE is 
inactive; consequently, the PWS-ICE is functional and acts in cis to positively regulate 
expression of the paternally expressed genes [11, 23, 24].  In the brain, the PWS-ICE 
facilitates the expression of a large polycistronic transcript containing the 
SNURF/SNRPN, SNORD115, SNORD116, and the UBE3A antisense (UBE3A-AS) genes 
[12, 25, 26].  The SNORD115 and SNORD116 gene clusters are a series of repeated 
snoRNA paralogs that are located within the introns of two snoRNA genes [27]. 
Canonical processing of the snoRNA genes releases the SNORD115and SNORD116 
RNAs from the host-gene transcript [12, 25, 26]. The UBE3A-AS represents the 3` end of 
the snoRNA genes and its expression across the paternal UBE3A allele is believed to be 
solely responsible for establishing the UBE3A imprint [18, 20, 25, 28-32]. The 
mechanism by which the UBE3A-AS silences UBE3A paternal-allelic expression and the 
functional significance of the UBE3A imprint in the brain are largely unknown. 
Dysregulation of genes in 15q11-q13 are associated with at least three human 
conditions:  Angelman syndrome (AS), chromosome 15q11-q13 duplication syndrome 
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(Dup15q), and Prader-Willi syndrome (PWS) [33-36]. Angelman syndrome is caused by 
mutations or epimutations that affect the expression or function of the maternally 
inherited UBE3A allele [37-39].  Angelman syndrome is characterized by developmental 
delay, loss of speech, ataxia, epilepsy, and a characteristic happy disposition [40].  
Conversely, Dup15q syndrome is associated with copy number gains of the maternally 
inherited UBE3A allele, and it shares many of the neurological features associated with 
AS (e.g., autism spectrum disorder, developmental delay, intellectual disability, 
epilepsy, ataxia, and reduced or absent speech [41].  The genotype-phenotype 
correlations of AS and Dup15q suggest that UBE3A is a dosage sensitive gene. Prader-
Willi syndrome is caused by paternally inherited deletions of 15q11-q13 that cause loss 
of expression of the SNORD116 cluster [42, 43].  Although, AS, Dup15q, and PWS are 
clinically distinct conditions, the causative genes underlying their respective phenotypes 
are transcriptionally, and perhaps functionally, linked. 
 
The UBE3A gene encodes an E3 ubiquitin-protein ligase that is a central member of the 
ubiquitin proteasome system [44-46]. The UBE3A protein possesses a conserved HECT 
domain (homologous to E6-AP C-terminus) that catalyzes the terminal step of the 
ubiquitination reaction [44]. The UBE3A gene expresses numerous alternatively spliced 
transcripts that encode at least three protein isoforms [47, 48].  The isoforms differ at the 
N-terminus and are each expressed in the brain; however, the precise cellular role of 
each isoform is unknown [44, 47, 48].  The UBE3A protein is known to ubiquitinate 
numerous proteins that are associated with a myriad of cellular pathways [49-54].  The 
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UBE3A protein also functions as a transcriptional co-activator of steroid hormone 
receptors, indicating numerous and diverse roles in the cell [55, 56]. The specific cellular 
pathways underlying the neurological deficits observed in AS and Dup15q, however, are 
currently unknown. 
 
The expression and dosage levels (i.e., RNA and protein) of UBE3A are clearly 
important for the human brain to develop and function properly. As such, it is perplexing 
that UBE3A is specifically imprinted in neurons and biallelically expressed in all other 
cell types. The imprint is not a random event, and it has been evolutionarily constrained 
for over 100 million years [10].  Taken together, these observations indicate the imprint 
plays a critical role in the development and/or function of the brain; however, the 
functional significance of the imprint has been largely ignored.   The doctoral 
dissertation outlined here attempts to answer some of the most pressing questions 
regarding the imprinting of UBE3A in the brain: (i) When during neurogenesis is Ube3a 
imprinted?; (ii) Is Ube3a only imprinted in neurons of the central nervous system?; (iii) 
What effect does the imprint have on the overall expression of Ube3a in brain?; (iv) 
Does the Ube3a-AS have a function independent of silencing Ube3a paternal-allelic 
expression?    Understanding the functional significance of the imprint is important 
because it may provide insight into the function of Ube3a, the snoRNAs, and the Ube3a-
AS in the brain.  Furthermore, it may reveal novel pathways to treat AS, PWS, and 
Dup15q.  
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2. LITERATURE REVIEW 
 
2.1 Genomic Imprinting 
2.1.1 History of Genomic Imprinting 
Diploid organisms possess two copies of their genome, one copy from each of their 
parents.  For the majority of genes, these two copies are expressed at relatively equal 
proportions; however, a small subset of genes express only one of the two parental 
alleles in a parent of origin specific matter, this is genomic imprinting [1].  The idea that 
genes or chromosomes had a parental identity was first described in 1960 using 
observations in gametogenesis and sex determination in Sciara, a species of gnat.  
During gametogenesis and sex determination, only the maternally inherited X 
chromosome is used [57].  The ability to track the maternally inherited X chromosome 
during both processes provided the basis of genomic imprinting theory.  This idea was 
supported during the development of nuclear transfer research.  Early attempts found 
that copies of both parental genomes were essential for proper development.  Embryos 
bearing two maternal genomes or two paternal genomes are not viable [58, 59].  This 
emphasized the existence of parental differences in the genome and supported the 
imprinting theory.  In 1991, DeChiara et al discovered the first imprinted gene.  They 
observed that mice heterozygous for an insulin-like growth factor II (Igf2) null mutation 
only showed an abnormal phenotype when the defective allele was inherited from the 
paternal side and demonstrated that the gene is expressed predominately from the 
paternal allele  [60].  Since the identification of Igf2 as an imprinted gene, approximately 
 7 
 
150 other imprinted genes have been identified in mammals [61].  Interestingly, 
although there is a high degree of correlation between species, all show variations in 
what genes are imprinted and where they are imprinted [62]. 
 
2.1.2 General Features of Imprinted Genes 
Imprinting has only been demonstrated in therian mammals, flowering plants, and some 
insects. In mammals, genomic imprinting exhibits temporal, tissue, and cell specificity 
and regulates genes involved in placental function, fetal growth, maternal nurturing, 
energy homeostasis, and neurologic function [7].  Interestingly, approximately half of 
imprinted genes displaying tissue specificity are expressed in the placenta and most of 
the remaining known tissue specific imprinted genes are expressed in the brain, however 
some imprinted genes are imprinted ubiquitously [63].  Theories discussing these 
observation are discussed in section 2.1.6 “Theories on the Evolution and Function of 
Genomic Imprinting.  Imprinted genes tend to occur in clusters throughout the genome 
and display parentally conserved expression patterns within these loci [64].  These 
clusters all contain an imprinting control element (ICE) that regulates the imprinted 
expression of the genes in the cluster in cis [65].  Furthermore, many of these clusters 
also contain long non-coding RNAs [66].  Inheritance and regulation of imprinted genes 
is mediated by epigenetic processes, that is heritable factors regulating temporal and 
spatial gene expression patterns independent of changes in DNA sequence [1]. 
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2.1.3 Inheritance of Epigenetic Modifications Regulating Genomic Imprinting 
DNA methylation is a heritable modification of cytosine at the 5 position most often 
found at cytosine-guanine (CpG) dinucleotides and associated with DNA silencing [66, 
67].  Discrete differences in methylation patterns of the germlines are termed germline 
differentially methylated regions (DMRs) [68].  Most ICEs are DMRs and appear to be 
the generationally inherited epigenetic marks that regulate imprinting [69].  During 
embryogenesis, the genomes of primordial germ cells migrating to the fetal gonad are 
stripped of the previously established epigenetic marks.  During gametogenesis de novo 
methylation occurs to reflect gamete specific methylation patterns and germline DMRs.  
Upon fertilization, the genome goes through another large scale change in epigenetic 
programming; however, imprinting control elements escape reprogramming and retain 
the mark of their parental lineage [61].  These actions establish the imprint in the 
individual and allow ICEs to persist and regulate imprinted clusters. 
2.1.4 Regulation of Imprinted Genes 
The mechanisms used by ICEs to mediate genomic imprinting vary between loci.  The 
ICE’s general activity is based on the ability of proteins to specifically bind methylated 
or unmethylated DNA and subsequently exercise an effect on the surrounding locus [65].  
This is the fundamental basis for the regulation of imprinting through three primary 
mechanisms:  DNA methylation, histone modification, and expression of non-coding 
RNAs. 
9 
2.1.4.1 DNA Methylation 
As discussed previously, DNA methylation occurs on cytosine residues throughout the 
genome.  The covalent modification of the 5 position of cytosine typically occurs at 
cytosine-guanine dinucleotides (CpG) islands in the genome and is most often associated 
with gene silencing.  Four DNA methyltransferases (DNMTs) regulate DNA 
methylation in cells and its stable inheritance in daughter cells [70-72].  De novo 
methylation, like that occurring in embryogenesis and gametogenesis, is regulated by 
DNMT3A and DNMT3B [73, 74].  The activity of DNMT3A proteins at imprinted loci 
during gametogenesis is regulated by an accessory protein, DNMT3L, which is essential 
to the imprinting process [75, 76].  Maintenance of the established DNA methylation 
patterns during cell division is controlled by DNMT1 [77].  The presence of methylated 
DNA at some locations can lead to passive methylated DNA spread surrounding the 
region.  The primary mechanism of action of methylated DNA is to recruit or block 
DNA binding proteins based on their ability to bind methylated DNA [78, 79].  DNA 
methylation blocks the ability of both RNA polymerase II (RNApolII) and the insulator 
protein CCCTC binding factor (CTCF) [80].  Blocking of RNApolII inhibits 
transcription leading to gene silencing and blocking binding of CTCF leads to local 
dysregulation of expression (discussed later).  Conversely, methylated DNA recruits 
other DNA insulators including polycomb repressive complexes (PRCs) responsible for 
repressive histone modifications [61]. 
10 
2.1.4.2 Histone Post-Translational Modifications 
Histones form the core of the nucleosome or “beads on a string” structure of DNA 
organization, and mediate the packaging of DNA within the cell.  The four core histone 
proteins - H2A, H2B, H3, and H4 - form an octamer made up of four core histone 
protein dimers and represent major contributors to chromatin structure [81, 82].  Each 
histone has an amino acid tail that protrudes from the nucleosome and can be modified 
[83]. These modifications include varying degrees of methylation (mono-, di-, tri-), 
acetylation, phosphorylation, ubiquitinylation, sumolation, and biotinylation and are 
restricted to lysine, serine, threonine, and arginine residues [84].   These covalent 
modifications directly and indirectly mediate chromatin structure and correlate with 
transcriptional activity of the genome [83, 84].   Imprinted genes are associated with four 
of these marks.  All ICEs are associated with the repressive mark histone 4 lysine 20 tri-
methylation (H4K20me3) [85].  Furthermore, repressive H3K9me3 and H3K27me3 are 
associated with imprinted gene promoters in overlap with active H4K4me3 [68, 85].  
Deciphering this “histone code” is a continuing project further complicated by theories 
and observation of combinatorial effects of these modifications, but recently bolstered 
by the ENCODE project [84, 86]. 
2.1.4.3 Non-Protein Coding RNAs 
The majority of imprinted clusters are associated with the expression of an oppositely 
imprinted long non-coding RNA (lncRNA) [65].  Despite this correlation, not all 
lncRNA transcripts are involved in direct regulation of the imprint [87].  Furthermore, 
11 
the posttranscriptional processing and functionality of these lncRNAs vary by locus, 
with some of them containing other functional RNA units [65].  The role these lncRNAs 
take in the imprint of their cluster is addressed at individual loci in the following section. 
2.1.5 Examples of Other Imprinted Genes and Regions 
2.1.5.1 Igf2/H19 Region 
The ICE regulating the Igf2/H19 locus is methylated on the paternal chromosome [88].  
Methylation of the paternal chromosome prevents the genetic insulator CTCF from 
binding to this site and allows a distant enhancer element to positively regulate Igf2 [80, 
89].  The ICE is also in close proximity to the promoter for H19, an lncRNA oriented in 
the opposite orientation of Igf2 [90].  This proximity leads to methylation of the 
promoter by unknown means, either passive DNA methylation spread or active targeting 
of DNA methyltransferases [65].  Conversely, absence of methylation on the maternal 
allele allows CTCF binding and the formation of a chromatin boundary between IGF2 
and H19.  This blocks the enhancer interaction with IGF2 and causes it to be silenced. 
The maternal H19 promoter is unmethylated and amenable to positive regulation by the 
same enhancer [80, 89].  Thus the Igf2/H19 locus is imprinted by the formation of a 
chromatin boundary and promoter methylation independent of expression of the lncRNA 
H19 (Figure 2A) [87]. 
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Figure 2.  Mechanisms of genomic imprinting at the Igf2/H19 and Igf2r locus. A) The insulin like 
growth factor 2 (Igf2) imprinting control element (ICE) is methylated on the paternal allele (filled 
lollipops).  The presence of DNA methylation inhibits binding of the DNA insulator, CTCF, and spreads 
to the promoter of H19.  Absence of CTCF allows positive regulation (green arrow) of Igf2 from the distal 
enhancer (E).  Absence of methylation of the maternal allele allows binding of CTCF and blocks enhancer 
action on Igf2 (red bar).  Lack of methylation at the H19 promoter allows expression on the maternal allele 
and positive regulation by the enhancer.  B) The insulin like growth factor 2 receptor (Igf2r) ICE is 
methylated on the maternal allele and overlaps the promoter of the lncRNA, Airn, blocking its expression.  
Absence of Airn expression on the maternal allele allows expression of Igf2r.  Absence of ICE 
methylation on the paternal allele permits expression Airn.  Airn overlaps the paternal Igf2r promoter, 
inhibiting recruitment of RNA polymerase II (Pol II) and promoting methylation.  Airn also positively 
regulates the paternally expressed Slc22a2 and Slc22a3 genes by an unknown mechanism.  Genes are 
colored to represent alleleic expression: pink = maternal, blue = paternal, grey = not expressed on this 
allele.  Arrows indicate 5’  3’ transcription. “M” represents maternal allele and “P” represents paternal 
allele. 
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2.1.5.2 Insulin-like growth factor 2 receptor (IGF2r) Locus 
The IGF2R locus is comprised of three maternally expressed transcripts and one 
paternally expressed lncRNA.  The ICE lies in an intron of Igf2r and is methylated on 
the maternal allele. This ICE corresponds to the promoter of the cluster’s lncRNA, Airn 
[91]. Expression of Airn on the paternal allele leads to repression of the three maternally 
expressed genes in cis [92]. The Airn transcript must be transcribed through the Igf2r 
promoter to induce methylation and silencing, but once established this methylation is 
sufficient to maintain the imprint in the absence of Airn [93, 94].  How AIRN expression 
induces IGF2R methylation is unknown.  Airn regulates silencing of one of the other 
genes by recruiting repressive histone methyltransferases without transcriptional overlap 
[95].  On the methylated maternal allele, inhibition of Airn expression allows the 
expression of the three sequential maternally expressed genes.  Thus, expression of the 
lncRNA at this locus is necessary for establishment and maintenance of the imprint 
(Figure 2B) [93, 94]. 
2.1.5.3 Kcnq1 Locus 
The Kcnq1 is centrally located in an imprinted cluster and flanked by a group placenta 
specific imprinted genes and a group of ubiquitously imprinted genes.  Again, the ICE 
element is in an intron of Kcnq1 and overlaps the promoter of the region’s lncRNA, 
Kcnq1ot1.  Although Kcnq1ot1 is very long and overlaps the promoter of Kcnq1, this 
overlap is not required for imprinting of Kcnq1.  A 5’ critical region of Kcnq1ot1 
mediates chromatin folding to bring the Kcnq1 promter into proximity with the ICE and 
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recruit histone transcriptional silencers [96] .  The requirement for Kcnq1ot1 expression 
to maintain the imprint is debated [96, 97].  Therefore, unlike the IGF2R locus, direct 
transcriptional overlap is not required for Kcnq1ot1 function.  Conversely, the lncRNA 
and transcriptional elongation is required for silencing of the other imprinted genes in 
the region by an undefined mechanism (Figure 3) [98]. 
 
 
Figure 3.  Mechanism of the Kcnq1 imprint.  The Kcnq1 imprinting control element ICE overlaps the 
promoter of the lncRNA antisense transcript KCNQ1ot1.  Methylation of the ICE (filled lollipops) on the 
maternal allele silences KCNQ1ot1allowing maternal expression of KCNQ1.   The paternal ICE is 
unmethylated promoting expression of  KCNQ1ot1 for an undetermined distance (dashed arrow).  The 
expression of KCNQ1ot1 mediates folding of the paternal allele to bring the paternal KCNQ1 promoter 
and ICE into proximity.  This juxtaposition promotes methylation of the KCNQ1 promoter (filled 
lollipops), blocking Pol II binding and silencing paternal KCNQ1.  The other genes of this locus (not 
pictured) are also imprinted, but regulated by an unknown mechanism. 
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2.1.5.4 Gnas Locus 
The Gnas ICE overlaps the maternally methylated Nespas-DMR over the promoter for 
the regions lncRNA, Nespas [99].  Paternal expression of Nespas from its unmethylated 
promoter leads to antisense transcriptional overlap with Nesp.  This action results in loss 
of the histone 3 lysine 4 trimethylation and subsequent DNA methylation over Nesp 
[100].  The Nespas DMR overlaps the promoter of GnasXL leading to its paternal 
specific expression [101].  A second maternally methylated DMR overlaps Exon1a and 
is responsible for the tissue specific imprint of Gnas [102, 103].  These collective 
elements – the Nespas transcript, Nespas ICE, and Exon1a DMR – work together to 
regulate usage of alternative 5’ exons that all share common parts of a group of 11 
downstream exons in Gnas.  On the maternal allele absence of the paternal transcripts 
allows both Nesp and Gnas to be expressed [104].  Therefore the imprint of this locus 
leads not to allele specific expression of a single gene, rather allele specific expression of 
alternative transcripts of single locus (Figure 4). 
 
2.1.5.5 Imprinted Loci without lncRNAs 
The Copg2/Mest region codes for two protein-coding genes and no identified lncRNA.  
These genes are arranged in antisense directions to each other, with overlapping 
3’UTRs.  Thus, expression of either gene precludes the expression of its counter-part.  
Mest is imprinted early in embryogenesis and hosts the only DMR in the region at its 
promoter.  In eutharians, Mest expresses a transcript during neuro-development that 
utilizes an alternative polyadenylation site within Copg2.  This transcriptional overlap  
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Figure 4.  Mechanisms of the Gnas locus imprint.  The Gnas locus contains an ICE and a differentially 
methylated region (DMR).  The ICE overlaps the promoter of the lncRNA Nespas.  The ICE is methylated 
on maternal allele and promotes methylation spread over the promoter of GnasXL (filled lollipops).  This 
permits expression of Nesp from the maternal allele.  Absence of methylation at the paternal ICE promotes 
expression of Nespas and GnasXL.  Nespas expression inhibits paternal Nesp expression and leads to its 
methylation (filled lollipops).  In tissues where the Exon 1A transcript is expressed, the maternal DMR is 
methylated (filled lollipops).  This leads to imprinted expression of Exon 1A from the paternal allele which 
subsequently inhibits expression of paternal Gnas (stripped box) leading to predominately maternal 
expression of Gnas in these tissues.  All of the coding transcripts at this locus – Nesp, GnasXL, Exon 1A, 
and Gnas – are functionally distinct but share the same 3’ exons demarcated by Gnas *. 
leads to the imprint of Copg2 not seen in representative metatherians that biallelically 
express Copg2 (Figure 5) [105, 106].  Finally, a mouse specific imprint of the 
Murr1/Commd1 gene provides evidence of another innocent bystander imprint.  In 
mouse an intronless zinc-finger gene, Zrsr1, lies in an antisense orientation in the first 
exon of Commd1 and contains a DMR at its promoter.  Thus, similarly to Mest/Copg2, 
the imprint of Commd1 appears to be incidental and a result of DMR regulation of Zrsr1 
specifically in mice [107]. 
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Figure 5.   Differential imprinting of the Mest/Copg2 locus.  In all tissues (M and P1). methylation of 
the maternal ICE (filled circular lollipops) leads to paternal specific expression of Mest.  In these tissues 
both Mest and Copg2 terminate at proximally located poly-adenylation sites (filled triangle lollipops).  In 
the developing brain (P2, dashed line) paternally expressed MestXL uses an alternate poly-adenylation 
sequence that lies within Copg2.  The overlap of MestXL and Copg2 lead to inhibition of paternal 
expression of Copg2 (red bar) and maternal allelic expression of Copg2 in brain. 
2.1.6 Theories on the Evolution and Function of Genomic Imprinting 
There are many theories addressing the purpose and evolution of genomic imprinting, 
however, none of them fully encompass the myriad of cases that have been presented in 
the literature [7, 108].  When discussing the origins of genomic imprinting it is important 
to appreciate the impact it has on the organism.  Genomic imprinting renders the 
organism functionally hemizygous for the allele, a historically poor indicator of fitness, 
allowing any deleterious changes in the active allele to be expressed [2, 3].  Therefore, 
the imprinting of a locus must have provided improved fitness in the face of possible 
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deleterious effects to be evolutionarily maintained [7, 109].  The host defense theory 
suggests that genomic imprinting derived from previously constructed cellular defenses 
to combat transposable elements [110].  Supporters point to the three key observations: 
1) the relative expansion of eukaryotic genomes over their evolutionary course, noting
particularly the increase of repetitive elements hallmarking transposons in therians 
compared to prototherians who lack imprinting; 2) the proximity of transposable 
elements to many imprinted clusters; and 3) the utilization of DNA methylation in 
silencing imprinted genes and transposable elements [7]. 
Another theory of the purpose of genomic imprinting is the kinship model or “parental 
conflict hypothesis.”  This idea proposes that parents have differing priorities for their 
offspring.  Males strive to have large and strong progeny who will pass on their traits 
with little consideration of this effect on the mother, who carries and cares for most 
offspring, or their potential half-sib littermates.  Conversely females would temper the 
males goals by having smaller progeny that would be less taxing of maternal resources 
during gestation and perinatally, ensuring survivability of larger litters [111].  This 
theory is strongly bolstered by the discovery of Igf2, an indicator of gestational size, as 
the first imprinted gene displaying paternal specific expression.  The observation that 
many imprinted genes are maternally expressed and found in the placenta and 
extraembyronic tissues gives further support particularly when considering that placental 
mammals, females especially, show much higher levels of investment in their progeny 
compared to other animals lacking imprinting [108].  
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The natural selection model posits that genetic imprinting is a much more fluid 
phenomenon used to link environmental factors to the fitness of the animal.  It suggests 
that environmental conditions during gestation play a role in the imprinting status of 
genes to promote fitness in the current climate the organism is being brought into.  This 
theory relies on the preponderance of imprinted genes in the brain, particularly neurons, 
indicating the ability to have long term behavioral effects on the organism.  Although 
environmental factors have been shown to mediate some epigenetic regulation, the 
evolutionary constraint, conservation, and stability of most imprinted genes does not 
support this as a prevailing theory for its origins [7, 108]. 
The ovarian time bomb/parthenogenic prevention model uses the observation that 
parthenogenesis does not occur in mammals, and when it does is disease based to the 
mother.  This proposes that imprinting evolved to prevent parthenogenesis in mammals 
through requiring both parental genomes to be present in a developing embryo [112].  As 
none of these theories fully encompass all the examples of known imprinting, it is likely 
a combination of all of these that led to the genomic imprinting phenomenon [7, 108].  
2.2 15q11-q13 Imprinted Region 
2.2.1 Overview 
The human 15q11-q13 region is syntenic to 7c in mouse and is highly conserved in 
eutherians.  This region encompasses numerous imprinted and non-imprinted protein-
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coding and non-protein coding transcripts.  The imprinted cluster is primarily paternally 
expressed: SNURF, SNRPN, MAGEL2, NDN, MKRN2, and the SNORD115 and 
SNORD116 clusters) [11, 12].  UBE3A is the single maternally expressed imprinted 
gene in the region [13].  The imprinted cluster in this region, the PWS/AS imprinted 
cluster, is associated with three genetic diseases affecting cognition and development) 
[33-36].  The mechanisms regulating the imprinting of this cluster and their functional 
significance are still being investigated. 
 
2.2.2 Evolution  
The imprinted cluster within 15q11-q13 arose 105-180 million years ago. A duplication 
event of Snrpb, part of a gene family that encodes a small ribonucleoprotein-associated 
proteins, created a brain specific homolog Snrpn 180-210 million years ago at the 
divergence of therians and prototherians [10, 113].  Subsequently, Snrpn was 
translocated into proximity and antisense to the highly conserved gene UBE3A after the 
divergence of eutherian and metatherians 105-180 million years ago [10].  Independent 
retrotransposition events gave rise to MAGEL2, MRKN3, and NDN in proximity to 
SNRPN [10, 114].  The source and evolution of the SNORD clusters in the SNRPN-
UBE3A region is unknown [10]. 
 
2.2.3 Imprinted Regulation 
This region is regulated by a bipartite ICE comprised of two DMRs, the Prader-Willi 
syndrome imprinting center (PWS-IC) and the Angelman syndrome imprint center (AS-
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IC) [21, 22].  The AS-IC is a germline DMR that is methylated in sperm and 
unmethylated in oocytes, but bound by a complex of approximately 7 proteins [24].  
Alternately, the PWS-IC is unmethylated in both germlines.  Upon fertilization, the 
maternal AS-IC is protected from methylation by its bound protein complex during 
epigenetic reprograming of the embryo.  At the same time, it is believed that this same 
protein complex interacts with the maternal PWS-IC, epigenetically flagging it for 
methylation by an unknown mechanism.  At the peri-implantation stage, the maternal 
PWS-IC epigenetic flag recruits DNA methyltransferases to gradually methylate the 
PWS-IC.  Subsequently, the protein complex dissociates from the maternal AS-IC 
allowing for passive methylation.  The location of AS-IC is not known in mouse.  The 
end result is that in developing and adult cells the PWS-IC, which overlaps the promoter 
and exon1 of SNRPN, is only unmethylated, and thus functional, on the paternal allele, 
allowing it to positively regulate paternal specific transcripts in the region [24]. The 
PWS-IC is believed to directly regulate paternally expressed genes as paternal deletion 
of the PWS-IC leads to loss of paternally expressed genes [115].  In addition to 
regulating regional protein coding genes, the PWS-IC overlaps the promoter of 
SNURF/SNRPN, the SNORD115 and SNORD116 RNA clusters, and the regions lncRNA 
[21, 25, 29].  This lncRNA is antisense to and overlaps UBE3A, resulting in neuron 
specific imprinting of UBE3A in the brain [20, 25, 28-32].  The precise mechanism by 
which this lncRNA mediates the imprint is as yet unknown.  Unlike other imprinted loci 
there are no repressive epigenetic marks surrounding UBE3A and the silenced paternal 
allele  has active epigenetic marks (namely H3K4me3) and is bound by RNA 
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polymerase II (RNApolII) [31].  Furthermore, little investigation has been made in 
investigating the functional significance of this imprint or its effect on Ube3a expression. 
 
2.2.4 The 15q11-q13 lncRNA 
The 15q11-q13 lncRNA is known as the UBE3A-ATS, UBE3A-AS, or LNCAT and is 
necessary to imprint UBE3A [18, 31, 32].  This lncRNA is at least two times larger than 
any other imprint associated lncRNA [25, 65].  This lncRNA spans the UBE3A-SNRPN 
intergenic region that houses multiple imprinted non-protein coding transcripts and 
exhibits splicing across the two resident clusters of small nucleolar RNAs (snoRNAs), 
SNORD115 and SNORD116 [12, 26].  The independence of the transcripts containing 
the SNORDs and the portion of the lncRNA overlapping UBE3A is currently debated 
[116, 117]. 
 
Small nucleolar RNAs are short (27-35 nucleotide) RNAs that are processed from 
spliced out elements of lncRNAs and leave behind an lncRNA host gene transcript.  
Small nucleolar RNAs regulate nucleolar ribosomes through mediating their 
methylation, but the function of the host genes is unknown [117].  SNORD115 and 
SNORD116 are not predicted to have this function.  SNORD115 regulates splicing of a 
serotonin receptor.  There are approximately 23 predicted targets of SNORD116, but no 
empiric evidence exists for any of them [117].  The host genes for these snoRNAs, 
SNORD115-HG and SNORD116-HG respectively, may also have a function as they are 
retained at their site of transcription forming RNA clouds, physical clusters of RNA 
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[116, 117].  The significance of these snoRNAs and SNORD-HGs require further 
investigation. 
 
2.2.5 Prader-Willi Syndrome 
Prader-Willi syndrome (PWS) was first described by Prader, Labhart, and Willi in 1956 
and occurs at an incidence of 1 in 10-30,000.  This disease is hallmarked by mild to 
moderate mental deficiencies, hypotonia leading to poor nursing in the newborn, short 
stature, hypogonadism, and hyperphagia – often leading to obesity – in children and 
adults [118].  This disease most often arises from paternal inheritance of large deletions 
of 15q11-q13.  Recently the disease was linked to specific defects in the SNORD116 
cluster of this imprinted region, but the pathophysiologic contribution of this defect to 
PWS is unknown [42, 43]. 
 
2.2.6 Angelman Syndrome 
2.2.6.1 Clinical Presentation 
Angelman syndrome (AS), first characterized by pediatrician Harry Angelman as 
“puppet children” in 1965, has a worldwide prevalence of 1 in 12-20,000 [119, 120].  AS 
is a severe neurodevelopmental disorder characterized by the hallmark findings of 
severely impaired speech, gait disturbance and/or tremulous movement of the limbs, 
developmental delay without regression, and the characteristic disposition of frequent 
laughter, happy demeanor, and “marionette-like” hand flapping [40, 120, 121].  These 
findings are present in all cases of AS and provide the basis of strong clinical suspicion 
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for the disease.  Furthermore, delayed head growth leading to microcephaly, seizures, 
characteristic abnormal electroencephalograms are found in more than 80% of cases and 
contribute to clinical suspicion of disease [40, 122].  There is a constellation of other 
symptoms with associations to AS, many of which relate to feeding and gastrointestinal 
related problems, changes in sleep/wake cycles, and ambulation.  It is important to note 
that most AS patients have a normal pre-natal and perinatal history.  The AS phenotype 
does not present before 6 months of age when developmental delay becomes evident and 
children lack abnormalities in typical laboratory profiles or gross changes in brain 
structure.  Furthermore it is important to recognize a multitude of diseases that may 
mimic AS in the infant [123]. 
 
2.2.6.2 Genetic Causes 
Angelman syndrome is caused by maternally inherited deficiencies in UBE3A.  The 
majority of cases (65%) result from large maternally inherited deletions of 15q11-q13.  
Furthermore, imprinting defects (ID) leading to a maternally active PWS-IC or complete 
paternal uniparental disomy (UPD) accounted for approximately 3% and 7% of cases 
respectively.  Point mutations in UBE3A are only responsible for approximately 15% of 
all cases.  These various genetic causes of AS do lead to subtle variations in the AS 
phenotype.  Cases of AS resulting from large deletions are the most severely affected 
group in all aspects of the disease with higher incidence of the less frequent associated 
AS phenotypes such as hypopigmentation.  Children with UPD and ID causes have the 
mildest phenotype with decreased incidence of seizures and improved growth and 
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movement.  Finally, children with non-deletion imprinting defects have the best 
expressive language skills with vocabularies of 50-60 words and the ability to formulate 
simple sentences [40, 121]. 
 
2.2.6.3 Diagnosis 
Genetic testing is the standard for diagnosing suspected AS cases.  DNA methylation 
testing of the SNRPN locus is the testing standard and can identify large maternal 
deletions, UPD, and imprinting defects.  DNA fluorescent in-situ hybridization (FISH) 
remains the standard for diagnosis of smaller deletions and chromosomal rearrangement.  
Children not diagnosed by these tests can be investigated for mutations in UBE3A.  
Despite several related testing measures, 15-20% of clinically diagnosed AS patients fail 
to have any genetic defect detected [122].   
 
There are currently no treatments for Angelman syndrome; however, various drugs and 
therapies are used to treat symptoms – seizures, irritability, etc. – to varying degrees of 
effect.  Identifying treatment possibilities addressing the root cause of AS is an active 
field of research  Daily et al demonstrated rescue of associative learning deficiencies in a 
mouse model through introduction of a viral vector expressing UBE3A [124].  Another 
group demonstrated that the imprinted paternal allele could be unsilenced using drugs, 
specifically topoisomerase inhibitors and subsequently showed that this occurred 
because of disruption of the paternally expressed antisense transcript [32].  Subsequently 
a mouse model that prematurely terminates the antisense transcript revealed that 
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reactivation of paternal Ube3a was able to rescue motor, learning, and neuronal 
functional deficiencies in AS mice to varying degrees, but had little effect on the AS 
behavioral phenotype [18].  These studies demonstrate the treatment potential for 
Angelman syndrome and a need for further understanding of its genetic regulation.  
 
2.2.7 UBE3A 
Ubiquitin protein ligase E3A (UBE3A) was first identified as E6-associated protein (E6-
AP) through its interaction with the E6-protein of human papillomavirus (HPV) leading 
to ubiquitination of p53 in the highly oncogenic strains of HPV, 16 and 18 [44, 46].  
UBE3A was mapped to the 15q11-q13 region in 1994 [13].  Subsequently, five 
transcriptional variants were identified, coding for three protein isoforms [47, 48].  Four 
transcriptional isoforms coding for the one unique and two shared protein isoforms have 
been identified in mouse.  The functional significance of the transcript variants and 
protein isoforms remains unclear, with the exception of mouse isoform 1 and human 
isoform 3 lacking the functional HECT domain. 
 
Although UBE3A was identified as the causative gene of Angelman syndrome, the exact 
pathophysiology of the disease remains to be elucidated.  The discovery of UBE3A 
characterized a unique family of E3 ligases sharing a conserved catalytic C-terminal 
domain, HECT (homologous to E6-AP C-terminus) [51, 125].  The 28 identified HECT 
E3 ligases are distinguished from other E3 ligases (RING-finger and U-box E3 ligases) 
because of their ability to play a direct catalytic role in the ubiquitination of their targets.  
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These HECT ligases are conserved from yeast to humans but vary greatly in size and can 
be divided into three subclasses based on the binding domains used for substrate 
recognition at the N-terminus.  Although many of the HECT E3 ligases have been 
associated with a variety of diseases, UBE3A is the only one shown to be the causative 
gene for a disease [45]. 
 
Twenty-four proteins have been described as targets of or associate with UBE3A 
independently of interactions with E6 protein.  The functions of these proteins includes: 
cell cycle regulation, chromosomal segregation during cell division, transcriptional 
regulation, histone modification, proliferation and differentiation, cell migration, protein 
aggregates associated with other movement and neurodegenerative disorders, and 
excitatory synapse formation [49-54, 126, 127].  UBE3A is also a target of itself [128].  
These pathways provide possible pathophysiologic pathways for the disease, but provide 
little conclusive evidence.  There are, however, two targets of UBE3A involved in the 
formation of excitatory synapse formation that suggest the most likely explanation for 
the phenotypes seen in AS.  Excitatory synapses are important neural connections in; the 
hippocampus, responsible for learning and memory; the cerebellum, responsible for 
motor coordination; and seizure initiation [129, 130].  Ephexin5 and Arc are both 
negative regulators of excitatory synapse formation and plasticity that are normally 
targeted for degradation by UBE3A.  Ephexin5 binds the post-synaptic receptor EphB 
and increases RhoA, inhibiting synapse maturation.  When EphB is bound by ligands on 
the presynaptic exon, it target Ephexin5 for degradation and the associated dendritic 
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spine and synapse can mature [131, 132].  Arc is a synaptic protein that mediates 
endocytosis of AMPA-glutamate receptors at the synapse following strong neural 
stimulation.  It was initially believed that this same action induced Ube3a upregulation 
to inhibit uncheck progression of Arc activity, but it now appears that Ube3a may 
negatively regulate Arc transcription [133, 134].  In either instance, loss of Ube3a leads 
to reduction in neural plasticity through loss of AMPA receptors.  Furthermore, 
excitatory synapse formation, particularly in response to experience dependent learning, 
upregulates UBE3A to promote inhibition of these negative regulators [129].  Thus 
UBE3A deficiency could directly inhibit appropriate synapse formation.  This is further 
supported by observations that mice deficient for maternal Ube3a show aberrant 
dendritic spine morphology [135].  It is also important to mention that UBE3A, 
demonstrates steroid-receptor coactivator activity independent of its ligase activity, but 
that the role of this function if any in AS is unknown [56]. 
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3. MATERIAL AND METHODS 
 
3.1 Mouse RNA-Sequencing Analysis 
RNA sequencing reads were obtained from the Mouse Genomes Project at the Wellcome 
Trust Sanger Institute under accession number ERP000591.  The RNA sequencing reads 
represent total RNA derived from tissues of female F1 progeny (C57BL/6J females x 
DBA/2J males [n = 6 heart and 6 brain]).  Mapping, normalized gene expression values, 
and SNV calling were computed using the CLC Genomics Workbench suite.  Reads 
were aligned to the mm9 genome assembly with the RefSeq annotation database using 
“RNA-Seq mapper”. The “Experiment tool” was used to calculate and normalize 
expression values between replicates and tissues.  The “Probabilistic variant calling 
algorithm” was used to identify SNVs.  These SNVs were then filtered to only include 
those previously identified in the parental lines, quality bases greater than 20, and called 
using at least 10 uniquely mapped reads.  Independent mapping of the samples using 
Tophat was conducted for use in DESEQ analysis.  Samples were mapped using default 
Tophat settings and –r set to 118.  This resulted in an average of 54 million reads per 
sample. For DESEQ analysis gene bed files were generated from the RefSeq track at 
UCSC (mm9) and counts per gene generated using bedtools multicov.  DESEQ 
normalization values were calculated from a restricted list of gene counts representing 
all genes with no known overlapping genes, alternative isoforms, or regional 
duplications in RefSeq.  The Cufflinks (v.0.0.6) tool in Galaxy (galaxyproject.org) was 
used to generate transcript predictions from merged brain CLC mappings using default 
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parameters (min isoform fraction = 0.05 and Pre mRNA fraction = 0.02).  Predicted 
annotations of the mouse Snord RNAs and Ube3a-AS were taken from the human 
RefSeq database (hg19) and PolyA-sequencing tracks were taken from the UCSC 
genome browser (http://genome.ucsc.edu/).  Visualization, Sashimi plot generation, and 
images of RNA-seq data were generated in IgV 2.3.  Sashimi plots were visualized to 
only display junctions with a depth of 10 reads in line with the threshold for SNVs 
identifications and represents 20% of average Ube3a intronic read coverage. 
 
3.2 Mouse Strains 
Ube3aYFP mice are a laboratory maintained strain [135].  Ube3a m-/p+ mice were 
generated in the laboratory of A. Beaudet and locally maintained on a C57BL/6 
background [136].  C57BL/6 mice (Jackson Laboratories) were used for breeding. 
 
3.3 Real-Time Polymerase Chain Reaction 
RNA was extracted from tissue samples using the Purelink RNA Mini Kit (Life 
Technologies).  The Superscript III First Strand Synthesis kit and oligo-dT primers (Life 
Technologies) were used for reverse transcription of processed RNA, and the High 
Capacity RNA to cDNA kit (Life Technologies) was used for reverse transcription of 
whole RNA.  Real-time PCR was performed using Taqman Gene Expression Master 
Mix and Taqman Gene Expression Assays per manufacturer’s protocol (Life 
Technologies).  Beta-2 microglobulin (Taqman Assay #Mm00437762_m1) was used as 
a ubiquitiously expressed endogenous control. Taqman Assay #Mm00839910_m1 was 
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used to assess Ube3a levels.  This primer and probe set targets an amplicon of 121 base 
pairs which spans exons 6 and 7 of Isoforms 1 and 3 and exons 8 and 9 of Isoform 2 of 
mouse Ube3a.   The reactions were run on an ABI 7900HT real-time PCR machine, and 
results were analyzed using the Ct method.  
 
3.4 Reverse Transcription PCR, Complementary DNA Cloning, and Sequencing 
RNA was extracted and reverse transcribed as described above.  cDNA was amplified 
using primers (APPENDIX Q) and GoTaq DNA polymerase (Promega, Madison, WI).  
Amplification mix consisted of:  8.5 l water, 5.0 l GoTaq buffer, 5.0 l betaine, 2.5 l 
MgCl2, 0.75 l dNTPs, 0.5l of each primer, 0.25 l polymerase, and 2 l of 1:5 diluted 
cDNA.  Reactions were amplified by denaturing at 95C for 5 minutes followed by 35 
cycles – 95C for 45 seconds, 57C for 45 seconds, 72C for 3.5 minutes – followed by 1 
cycle of 72C for 7 minutes.  Products were resolved on 1% agarose gel. The resulting 
PCR products were gel purified using the Zymoclean Gel DNA Recover Kit (Genesee 
Scientific, San Diego, CA).  Incubation of the purified products with GoTaq polymerase 
and dNTPs at 72 C for 15 minutes added T overhangs for T/A cloning.  The TOPO TA 
Cloning Kit for Subcloning (Life Technologies) was used according to manufacturer’s 
protocol.  Plasmids containing the cloned products were then sequenced.  Some PCR 
products were sequenced from direct PCR products.  The resulting sequences were 
trimmed and aligned to the mouse mm9 using UCSC BLAT. 
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3.5 Western Blot Analysis  
Tissues and cells were disrupted for western blot analysis using a 1% Nonidet P40/ 
0.01% SDS lysis buffer with protease inhibitors (Roche, Indianapolis, IN).  The resulting 
lysates were mixed 1:1 with Laemmli Loading Buffer (Bio-Rad, Hercules, CA).  The 
samples were run on SDS-PAGE gels (7.5%) at 25V overnight, and transferred to 
nitrocellulose blots at 100V for 2 hours.  To control for loading, the blots were dyed with 
Ponceau stain (Sigma-Aldrich) and digitally photographed.  The blots were then blocked 
in 5% milk in Tris-buffered saline plus Tween-20 (T-TBS) for one hour at room 
temperature. Primary antibody (APPENDIX R) was diluted in 2.5% milk/T-TBS and 
incubated on the blot for one hour at room temperature. After three 15 minute washes in 
T-TBS, the secondary antibody (APPENDIX R) was diluted 1:2000 in 2.5% milk/T-
TBS and incubated on the blot for one hour at room temperature.  Three 15 minute 
washes in T-TBS were performed before developing with Clarity Western ECL 
Substrate (Bio-Rad), according to protocol.  Blots were imaged using the FluoroChem 
system.  Analysiss of western blot imaging was conducted in ImageJ as outlined in 
Gassman et al, using the Ponceau stain image analysis for blot normalization  [137]. 
 
3.6 Tissue Perfusion and Immunofluorescence  
Mice were anesthetized with 0.5-1.0 mLs of 20mg/mL Avertin (Sigma-Aldrich, St. 
Louis, MO) via intraperitoneal injection.  Mice were perfused with ice-cold phosphate 
buffered saline (PBS) and 4% paraformaldehyde in PBS. Dissected brains and colons 
were post-fixed in 4% paraformaldehyde solution overnight and then cryoprotected in 
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30% sucrose solution.  50 µm sections were cut on a cryostat and stored in PBS.  
Sections were washed in PBS and blocked in 0.3% Triton-X100 in PBS (T-PBS) plus 
5% normal goat or donkey serum for 1-2 hours at room temperature with gentle 
agitation.  Primary antibodies were incubated with sections for 48 hours at 4˚C with 
gentle agitation (APPENDIX R). Sections were washed 3 times in 0.1% Tween 20 1x 
PBS for 15 minutes each and then incubated with fluorescently labeled secondary 
antibodies (APPENDIX R) for 24 hours at 4˚C in the dark.  Sections were washed 4 
times in 0.1% Tween 20 1x PBS for 15 minutes each.  Nuclei were labeled by adding 
TO-PRO-3 (Invitrogen) at 1:1000 dilution in the third wash.  Sections were mounted on 
glass slides with Vectashield (Vector Laboratories, Burlingame, CA) mounting reagent.  
Confocal images were obtained using a LSM 510 META NLO multiphoton microscope 
(Zeiss, Oberkochen, Germany). Confocal microscopy was performed in the Texas A&M 
University College of Veterinary Medicine & Biomedical Sciences Image Analysis 
Laboratory, supported by NIH-NCRR (1 S10 RR22532-01). See supplementary imaging 
methods for pertinent immunofluorescent imaging collection settings.  
3.7 Neural Stem Cell Cultures and Differentiation 
Methods for neural stem cell culture and differentiation were adapted from Shetty et al 
[138]. The hippocampal formation (HF) was removed from E17.5 mice.  The HF was 
enzymatically digested using a 10X Trypsin-EDTA solution, triturated into a single cell 
suspension and then seeded in neural stem cell medium.  The neural stem cell media 
consists of DMEM-F12 (Invitrogen, Carlsbad, CA), B-27 supplement (Invitrogen), 
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progesterone, putresceine (Sigma-Aldrich), epidermal growth factor (Sigma-Aldrich), 
glucose, Penicillin/Streptomycin (Invitrogen), Insulin-transferrin-sodium selenite 
(Sigma-Aldrich), HEPES, and heparin. The neurospheres were passaged every 3-4 days 
by spinning down and incubating in Tryp-LE (Invitrogen) for 20 minutes before 
resuspending and dissociating in NSC media.  To differentiate the NSCs into neurons, 
the neurospheres were dissociated as above and plated into neuron growth media 
(Neurobasal-A [Invitrogen], B-27 supplement [Invitrogen], and Glutamax [Invitrogen]) 
and on glass coverslips coated with poly-ornithine [Sigma-Aldrich] and laminin 
[Invitrogen] at a density of 380,000 cells per well in a 12-well cell-culture plate.  NSCs 
and neurons were maintained in humidified incubators at 37˚C and 5% CO2. For 
fixation, cells were washed twice with PBS, fixed in 4% paraformaldehyde in  PBS for 
15 minutes with gentle agitation, and washed three times in 1x PBS.  
Immunofluorescence staining and imaging of the neurospheres and neurons were 
performed as detailed above for the brain tissues, with blocking and incubation with 
antibodies lasting one hour each.  
3.8 Primary Neuronal Cell Cultures 
Culturing of primary neurons was conducted as in Hilgenberg et al. with only slight 
departures from physical handling and culturing media [139].  Briefly, P1 pups were 
sacrificed by decapitation and brains removed to dissection solution.  Meninges were 
removed and brains were coronally sectioned by hand using #20 surgical scalpels.  
Cortical rind was dissected from coronal sections, minced to ~1mm pieces and digested 
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in the presence of papain (Worthington Biochemical).  Tissues were washed multiple 
times to stop enzyme activity and clean tissues.  Brain pieces were triturated 8-10 times 
in neuron media (see above) using a 1mL pipette.  Cells were counted and plated at a 
density of 6400 cells/well in optical bottom 96 well plates (Thermo Scientific) pretreated 
with poly-d-lysine (Sigma Aldrich) or 40,000 cells/well in 24 well plates with 12mm 
coverslip coated in poly-d-lysine and maintained in humidified incubators at 37˚C and 
5% CO2.  Cells were supplemented with an equal volume of neuron media conditioned 
on previously plated cerebellar astrocyte cultures after 24 hours.  Fifty percent of media 
was changed at 4 and 7 days in vitro (DIV) using fresh conditioned neuron media.  For 
treatment of cells, topotecan hydrochloride (Sigma Aldrich) was added to replacement 
media at a 600nM concentration to bring final concentration on cells to 300nM.  
Similarly DMSO was added to replacement media at a concentration of 0.4% to bring 
final concentration to 0.2% on cells.  Treatments were carried out with media change at 
7 DIV.  Staining and imaging of 24 well coverslips was carried out as for differentiated 
neurons above.  Staining of 96 well plates was carried at as previously stated for 
differentiated neurons after 11 day in vitro using YFP, NeuN, and TO-PRO-3 staining as 
in in vivo studies.  Imaging was performed on a GE In Cell Analyzer 6000 at Texas 
A&M University Health Science Center Institute for Biotechnology, Center for 
Translational Cancer Research.  Wells were tiled using a 10x objective with 0% overlap. 
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3.9 Astrocyte Cultures 
Cerebellum from similarly P1 pups were collected as above, meninges removed, and 
loosely dissociated by pipetting with 1mL pipette in 10x trypsin and incubated at 37 ˚C 
and shaken at 750 rpm for 1 minute before being allowed to settle and resuspend in 10% 
Fetal bovine serum in DMEM-F12 (Invitrogen, Carlsbad, CA) supplemented with 
glucose and Penicillin/Streptomycin (Invitrogen) for another 1 minute shaking 
incubation.  Tissues were allowed to settle and then resuspended and triturated into 
single cell suspension in 10% FBS culturing media before being plated into 5mls of 
media in 25cm
2
 flasks and maintained at 37˚C and 5% CO2. 
3.10 Analysis of Immunofluorescent Images 
Image J (NIH) was used in image preparation and to measure gray scale values of 
individual cells in images of non-high throughput cell culture and in vivo studies.  
Neurons were delineated from other cells by positive Tubb3, Map2, or NeuN staining.  
The fluorescence of each cell was expressed as YFP intensities overlapping neuronal 
TO-PRO staining. 
Analysis of high throughput imaging was carried out with the In Cell Developer 6.0.  
Briefly, individual track masks were generated for both TO-PRO-3 nuclear stain and 
NeuN staining channels by optimizing inclusion and exclusion parameters based on size 
and intensity on randomly selected images.  A third mask was generated of the 
overlapping area between objects in the TO-PRO-3 and NeuN masks and YFP intensity 
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was measured for these objects.  Measurements and statistics were examined as an 
average of measured YFP intensities per well. 
 
3.11 Statistical Analyses 
All statistical analysis was carried out in R (3.0.1 -- "Good Sport").  The Shapiro-Wilk 
normality test (shapiro.test) was run on all data sets.  Variance in all comparisons was 
tested using the F test to compare two variances (var.test).  Significance was tested using 
R defaults when controlling for normality and variance.  A Two Sample t-test was used 
to compare normally distributed data sets with equal variance.  A Welch Two Sample t-
test was used to compare normally distributed data sets with unequal variance.  
Wilcoxon rank sum test was used to compare data sets when at least one was not 
normally distributed but both had equal variance.  Wilcoxon rank sum test with 
continuity correction was used to compare data sets when at least one was not normally 
distributed and there was unequal variance.  Ashman's D was chosen as a measure of 
severability of two sub-populations and calculated by hand. 
 
For comparisons of total Ube3a:YFP expression between peripheral and central neurons 
and DIV 1 and DIV 16 NSC differentiated neurons random sums were used.  Briefly, 
data sets for each allele were randomized and paired (n= 3) and summed.  This generated 
3 lists of paired sums for each sample (DIV 1 neurons, DIV 16 neurons, peripheral 
neurons, central neurons).  All pairwise comparisons were tested as above, and the 
lowest P value was reported. 
 38 
 
3.12 Graphs 
All graphs were generated in GraphPad Prism 6™. 
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4. RESULTS 
 
4.1 Ube3a Allelic Expression Does Not Correlate with Its RNA and Protein Levels 
The transcriptional profiles, steady-state total RNA (toRNA) levels, and single 
nucleotide variants of RNA transcripts (RNA-genes, intergenic and intragenic RNAs of 
unknown function) and protein-coding genes within and flanking the mouse 7C 
imprinted locus were examined using RNA-sequencing data derived from brain and 
heart tissues of F1 hybrid mice (Figure 6A-B).  Ube3a was imprinted with preferential 
maternal-specific expression in the brain (M:P ratio = 83:17) and biallelically expressed 
in heart (43:57) (Table 1 and Appendix A-C).  Numerous RNA transcripts identified in 
the Ube3a-Snrpn region were expressed only in brain and exclusively from the paternal 
chromosome.  These transcripts were consistent with the expression of the long 
polycistronic RNA transcript involving Snurf/Snrpn, Snord116/Ipw, Snord115, and the 
Ube3a-AS (Table 1 and Appendix A-C). Overall, the normalized toRNA levels of 
protein-coding genes, with the exception of Nipa2 and Peg12, were higher in brain than 
in the heart (P < 0.05). The Ube3a toRNA levels in brain were 1.6-fold higher than in 
heart, and toRNA levels of the parental alleles diverged between the tissues (maternal  
allele: brain>heart [P < 0.001]; paternal allele: brain<heart [P = 0.016], [Table 1 and 
Appendix A-C]).  Additional assays were used to validate the Ube3a RNA-seq data, 
determine Ube3a messenger RNA (mRNA) steady-state levels, and examine additional 
brain regions and tissues. Accordingly, Ube3a toRNA and mRNA levels were 2- to 18-
fold higher in each brain region relative to the other tissues (P = 0.002) (Figure 7A) and  
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Figure 6.  RNA-seq mapping by tissue for C57BL/6J x DBA2/J hybrid mice. A)  Representative sample of total read counts across mouse 7C 
imprinted region summarized as a 10bp window BigWig file.  Black, brain; Red, heart. B)   Representative sample of total read counts across Ube3a-
Snprn intergenic region containing proposed Ube3a-AS expression summarized as a 10bp window BigWig 
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Table 1.  Summary of relative expression levels and allelic ratios of genes in the mouse 7c 
imprinted region as determined by RNA-seq analysis. 
Gene 
Heart Mean 
Expression 
Hippocampus Mean 
Expression 
Fold Increase 
in Brain 
Heart 
Allelic Ratio 
M:P 
Hippocampus 
 Allelic Ratio 
M:P 
Tubgcp5 2.94 8.39 2.86*** 40 : 60 48 : 52 
Cyfip1 4.35 7.86 1.81** 39 : 61 59 : 41 
Nipa2 4.12 4.68 1.13 ND ND 
A230056P14Rik 0.53 4.84 9.16*** 41 : 59 54 : 46 
Nipa1 2.38 12.93 5.44*** ND ND 
Herc2 3.70 23.51 6.35*** 43 : 57 52 : 48 
Oca2 0.00 0.12 ∞ ND ND 
Gabrg3 0.01 2.72 249.05*** ND 50 : 50 
Gm9962 0.00 0.12 ∞ ND ND 
Gabra5 0.00 69.96 ∞*** ND ND 
Gabrb3 0.02 84.92 4959.63*** ND 51 : 49 
Atp10a 0.53 1.62 3.04*** 36 : 64 53 : 47 
Ube3a 8.05 13.29 1.65* 43 : 57 83 : 17 
C230091D08Rik 8.53 14.09 1.65* 45 : 55 41 : 58 
Ipw 0.00 4.75 ∞*** ND ND 
D7Ertd715e 4.54 12.98 2.86** 0 : 100 0 : 100 
Snrpn-Snurf 26.63 152.96 5.74*** 0 : 100 0 : 100 
B230209E15Rik 0.00 9.87 ∞** ND 0 : 100 
A230057D06Rik 0.00 0.42 ∞*** ND 0 : 100 
A330076H08Rik 0.00 1.41 321.53*** ND 0 : 100 
Ndn 6.12 105.14 17.18*** 0 : 100 0 : 100 
Magel2 0.00 0.25 ∞** ND ND 
Mkrn3 0.10 0.20 2.04 ND 0 : 100 
Peg12 0.18 0.04 0.25 ND ND 
Chrna7 0.02 12.99 662.37** ND 56 : 44 
ND = No allelic data; * = p<0.05, ** = p<0.01, *** = p<0.001 
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Ube3a protein levels were 2.8- to 3.5-fold higher in the brain relative to the other tissues 
(P < 0.001) (Figure 7B), indicating a nonlinear relationship between the number of 
expressed Ube3a alleles and RNA or protein levels. 
 
 
Figure 7.  The mouse 7C imprinted domain is highly expressed in brain compared to other tissues. 
 A) Normalized Ube3a levels from toRNA and mRNA isolated from wild-type mouse tissues.  Levels are 
shown as the ratio of expression in tissues relative to heart, normalized to the housekeeping gene Beta-2 
microglobulin. B) Normalized Ube3a protein levels isolated from wild-type mouse tissues.  Levels are 
shown as the ratio of expression in tissues relative to heart, normalized by Ponceau total protein stain.  n = 
4. *** P< 0.001. Ct, cortex; Hp, hippocampus; Ht, heart; Lg, lung. 
 
4.2 Ube3a Is Not Imprinted in Neurons of the Peripheral Nervous System 
The Ube3a gene is imprinted in neurons of the central nervous system (CNS), but its 
imprinting status in neurons of the peripheral nervous system (PNS) is unknown [19, 
 43 
 
135].  Therefore, we used quantitative immunofluorescence imaging of the Ube3a:YFP
 
reporter protein
 
in Ube3a
YFP/+ 
and Ube3a
 +/YFP 
mice to infer Ube3a parental-allelic 
expression patterns in myenteric neurons of the colon. We detected both paternal- and 
maternal-Ube3a:YFP
 
in myenteric neurons; however, the level of protein generated by 
each parental allele was skewed toward the maternal allele (58:42; P = 0.033) (Figure 
8A-B).  Comparisons between myenteric and hippocampal granular neurons of the same 
animal revealed similar levels of total Ube3a:YFP (P = 0.113) between the two neuronal 
cell types, suggesting Ube3a allelic expression patterns do not correlate with total Ube3a 
protein levels in neurons (Figure 8A-B). 
 
4.3 The Ube3a Imprint Is Developmentally Regulated 
Our observation of elevated Ube3a protein in the brain and restriction of the imprint to 
CNS neurons, prompted us to investigate the developmental timing of the imprint in two 
neurogenic niches of the adult brain: the subventricular zone (SVZ) of the lateral 
ventricles and the subgranular zone (SGZ) of the dentate gyrus (DG).  In the SVZ, 
paternal- and maternal- Ube3a:YFP were detected in neural stem cells and precursor 
cells lining the lateral ventricles and in immature neurons throughout the rostral 
migratory stream (RMS) (Figure 9A-D). In the olfactory bulb (OB), maternal-
Ube3a:YFP levels were visually similar to adjacent neurons in the cortex (Figure 9C).   
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Figure 8.  Ube3a is biallelically expressed in mature neurons of the peripheral nervous system.  A) 
Immunofluorescence of mature neurons in the central (dentate gyrus) and peripheral (myenteric ganglia) 
nervous system of Ube3a
+/YFP
 and Ube3a
YFP/+
 mice.  YFP, Ube3a:YFP; NeuN, neuronal nuclei RBFOX3; 
TO-PRO-3 Iodide nuclear stain.  Scale Bar, 10m.  B) Relative Ube3a:YFP expression as fold change 
over wild-type controls and total expression as a sum of allelic expression.  n = 26 central and 15 
peripheral Ube3a
+/YFP
, 20 central and 30 peripheral Ube3a
YFP/+
, 12 central and 5 peripheral Ube3a
+/+
. * P 
< 0.05, ** P < 0.01,  *** P < 0.001, N.S. not significant. 
 
Paternal-Ube3a:YFP was only weakly detected in the OB, but more abundant than 
observed in cortical neurons, which may have resulted from increased cellular density in 
the OB (Figure 9D).  A sharp decline in paternal-Ube3a:YFP was observed at the 
boundary between the RMS and OB, which mirrored the expression pattern of 
doublecortin-labeled immature neurons in the RMS.  In the DG, maternal-Ube3a:YFP 
was detected in the neurogenic niche and granular cortical layer neurons (Figure 10A), 
whereas paternal-Ube3a:YFP was only detected in the neurogenic niche (Figure 10B).  
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Figure 9.  Ube3a is biallelically expressed in the subventricular zone neural stem cell niche of the adult central nervous system 
(CNS) in vivo.  A) Subventricular zone of Ube3a+/YFP and Ube3aYFP/+  mice showing biallelic expression of Ube3a:YFP.  10x 
Magnification.  Scale Bar = 100m.  B) Subventricular zone of Ube3a+/YFP mice demonstrating paternal Ube3a expression in GFAP 
expressing neural stem cells, Nestin expressing neural progenitor cells, and PSAN expressing neural progenitor cells.  43x 
Magnification.  Scale Bar = 20m.  C-D)  Immunofluorescence of neural differentiation markers and allelic Ube3aYFP in the rostral 
migratory stream of adult mice (6-8 weeks), C = Ube3a+/YFP and D = Ube3aYFP/+.  Scale bar, 500m.  YFP, Ube3a:YFP; GFAP, glial 
fibrillary acid; PSAN, polysialylated neuronal cell adhesion molecule, DCX, doublecortin – immature neurons ;  RMS, rostral 
migratory stream – demarcated by dashed lines ; OB, olfactory bulb ; *, lateral ventricles 
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Figure 10.  Ube3a is biallelically expressed in the neural stem cell niche in the subgranular zone of 
the dentate gyrus of the adult central nervous system (CNS) in vivo.   A-B) Dentate gyrus of adult (6-8 
weeks) Ube3a
YFP/+ 
(A) and Ube3a
+/YFP  
(B) mice. YFP, Ube3a:YFP;  Topro, TO-PRO-3 Iodide nuclear 
stain; GCL, granular cortical layer; SGZ, subgranular zone.  10x Magnification.  Scale Bar, 50m.  C) 
Single cell immunofluorescence neural maturation from SGZ of adult (6-8 weeks) Ube3a
+/YFP
 mouse. 10x 
Magnification.  Scale Bar = 20m.  YFP, Ube3a:YFP; GFAP, glial fibrillary acid; PSAN, polysialylated 
neuronal cell adhesion molecule; DCX, doublecortin; NeuN, neuronal nuclei RBFOX3; SGZ, subgranular 
zone; GCL, granular cortical layer. 
 
Colocalization studies showed that paternal-Ube3a:YFP was present in neural stem cell 
radial glia, neural precursor cells, and immature neurons; however, it was minimally 
present in mature granular neurons (Figure 10C). Taken together, these data suggest 
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Ube3a transitions to an imprinted state as immature neurons differentiate into 
developmentally mature neurons. 
4.4 Ube3a Maternal-allelic Expression Increases During Establishment of the 
Imprint 
We next quantified steady-state paternal- and maternal-Ube3a:YFP levels in neural stem 
cell derived neurons and astrocytes during the early stages of cellular differentiation.  
Primary neural stem cell/progenitor cell (NSC) cultures were established from the 
hippocampal formation of Ube3a
YFP/+ 
and Ube3a
+/YFP 
mice and differentiated into
astrocytes and neurons.  The allelic ratios were equivalent (~50:50) in the NSC cultures 
after multiple passages in culture (Figure 11A-C).  Similarly, paternal- and maternal- 
Figure 11.  Biallelic expression of Ube3a is maintained in hippocampal stem/progenitor cell cultures. 
A) Immunofluorescence of Ube3a:YFP expression in neurospheres derived from hippocampus of
Ube3a
+/YFP
 and Ube3a
YFP/+
.  Scale Bar, 100m.  B)  Western blot of hippocampal NSCs from Ube3a+/+, 
Ube3a
+/YFP
, and Ube3a
YFP/+
 mice probed for Ube3a.  C) Quantification of relative allelic expression of 
Ube3a in NSCs by western blot analysis. 
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Ube3a:YFP were equal (51:49; P = 0.749) in NSC-derived astrocytes at 16 days in vitro 
(DIV) (Figure 12 A-B).  In NSC-derived neurons, paternal- and maternal-Ube3a:YFP  
 
 
Figure 12.  Biallelic expression of Ube3a in neural stem cell derived astrocytes.  A)  
Immunofluorescence of Ube3a:YFP expression in astrocytes at 16 days post differentiation from NSCs 
derived from hippocampus of Ube3a
+/YFP 
and Ube3a
YFP/+ 
mice. YFP, Ube3a:YFP; GFAP, glial fibrillary 
acid; TO-PRO-3 Iodide nuclear stain.  Scale Bar, 100m.  B) Quantification of relative expression in 
differentiated astrocytes. n = 15 Ube3a
+/YFP 
and 14 Ube3a
YFP/+ 
. N.S., not significant. 
 
were equal (54:46; P = 0.277) at 1 DIV; however, at subsequent time-points (4 DIV 
[61:39; P = 0.019]; 8 DIV [67:33; P < 0.001]; 16 DIV [86:14; P < 0.001]), maternal- and 
paternal-Ube3a:YFP levels diverged at similar rates (Figure 13A-C).  During the course 
of the experiment, paternal-Ube3a:YFP levels decreased by 0.7-fold (P < 0.001); 
conversely, maternal-Ube3a:YFP levels increased by 1.7-fold (P < 0.001). Summation 
ofmaternal-Ube3a:YFP and paternal-Ube3a:YFP at each time point revealed that the 
total level of Ube3a:YFP remained relatively constant over the course of the experiment 
(P = 0.313 [Figure 13C]).  Furthermore, at 16 DIV, paternal-Ube3a:YFP was still 
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detectable in the neurons, suggesting the imprint did not completely silence paternal-
allelic expression; instead, it reduced its expression, consistent with prior observations 
[135].  Collectively, these data suggest that maternal-allelic expression increases during 
the acquisition of the imprint to maintain a constant level of total Ube3a protein in 
neurons of the central nervous system. 
 
4.5 Pharmacological Inhibition of the Ube3a-AS Affects Both Ube3a Maternal- 
and Paternal-allelic Expression 
Our observation of increased maternal-allelic expression during neurogenesis suggested 
the existence of a dosage compensating mechanism that regulated Ube3a expression.  To 
examine whether such a mechanism existed, we reactivated paternal-allelic expression in 
primary cortical neurons by inhibiting expression of the Ube3a-AS via topotecan. 
Primary cortical neurons derived from Ube3a
YFP/+ 
and Ube3a
+/YFP 
mice (P1) were 
cultured for 7 DIV and treated with topotecan.  Paternal-Ube3a:YFP and maternal-
Ube3a:YFP levels were then examined 4 days afterwards (11 DIV) by quantitative 
immunofluorescence imaging.  The topotecan treatment reactivated the paternal allele; 
however, the level of reactivation was only 83% of the maternal allele in control 
neurons.  Unexpectedly, topotecan treatment also increased maternal-Ube3a:YFP
 
(1.2-
fold relative to untreated maternal-Ube3a:YFP [P = 0.018]). The increased protein levels 
from each allele yielded a net 2-fold increase of Ube3a:YFP (Figure 14A-B).  Further 
investigation of the data, however, revealed two populations of neurons in the untreated  
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Figure 13.  Ube3a maternal-allelic expression increases during neurogenesis.  A)  
Immunofluorescence of allelic Ube3a
YFP
 in neurons differentiated from neural stem cell 
(NSC) cultures at 1 and 16 day(s) in vitro (DIV).  YFP, Ube3a:YFP; Tubb3,  tubulin 
III; Topro, TO-PRO-3 Iodide nuclear stain.  Scale bar, 25m.  B) Quantification of 
allelic Ube3a:YFP in neurons differentiated from NSCs at 1 DIV (n = 13 Ube3a
+/YFP
, 14 
Ube3a
YFP/+
), 4 DIV (n = 14 Ube3a
+/YFP
, 13 Ube3a
YFP/+
), 8 DIV (n = 15 Ube3a
+/YFP
, 15 
Ube3a
YFP/+
), and 16 DIV (n = 14 Ube3a
+/YFP
, 13 Ube3a
YFP/+
), relative to total 
Ube3a:YFP at 1 DIV. ** P < 0.01, *** P < 0.001 between alleles. C)   Summation of 
total Ube3a:YFP in neurons differentiated from NSCs in A and B.  N.S. not significant. 
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Figure 14.  Pharmacological inhibition of the Ube3a-AS affects Ube3a maternal- and paternal-allelic 
expression.  A) Immunofluorescent images of untreated topotecan treated primary neurons from 
Ube3a
+/YFP 
and Ube3a
YFP/+ 
mice.  NeuN, neuronal nuclei RBFOX3; TO-PRO-3 Iodide nuclear stain.  10x 
magnification.  Scale bar, 100m.  B) Average relative Ube3a:YFP expression by well in 96 well plate. n 
= 10 wells Ube3a
YFP/+ 
untreated,  6 Ube3a
YFP/+ 
topotecan,  8 Ube3a
+/YFP 
untreated, 8 Ube3a
+/YFP 
topotecan. 
** P < 0.01,  *** P < 0.001, N.S. not significant. C) Frequency distribution plot of Ube3a:YFP intensities 
of individual cells as a percent of total neurons for Ube3a
YFP/+ 
untreated, Ube3a
YFP/+ 
topotecan, and 
Ube3a
+/YFP 
topotecan.  D)  Total neuron counts of Ube3a
YFP/+ 
untreated, Ube3a
YFP/+ 
topotecan.  Error bars 
= standard error of the mean. 
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Figure 14. Continued 
 
cultures that were distinguished by low and high maternal-Ube3a:YFP levels (Ashman’s 
D>2 [Figure 14C]).  The low maternal-Ube3a:YFP subpopulation was not present in the 
topotecan treated Ube3a
YFP/+ 
neuronal cultures, rather only the high maternal-
Ube3a:YFP was present.  Therefore, the increased maternal-Ube3a:YFP levels observed 
in the topotecan treated neurons was in fact due to loss of the low expressing 
subpopulation.  Likewise, only one population (i.e., based on Ube3a:YFP level) of 
neurons was observed in the topotecan treated Ube3a
+/YFP
 
 
neuronal cultures; however, 
the neurons represented an intermediate subpopulation (Figure 15C).  The effect of 
topotecan on the two subpopulations was not the result of neuronal cell death (P = 0.182 
[Figure 14D]), indicating that the treatment only increased maternal-Ube3a:YFP in the 
low expressing subpopulation and not the high expressing subpopulation. To account for 
potential artifacts stemming from the Ube3a:YFP protein and address direct 
measurement of total Ube3a protein levels, the experiment was replicated using primary 
cortical neurons derived from wild-type mice. Again, the topotecan treatment increased 
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Ube3a protein levels by approximately 2-fold (Figure 15A-B). Consistent with prior 
observations, the paternal allele was reduced but not completely silenced in vivo or in 
vitro (~1.8 to 3.2% of the maternal allele, P < 0.001 [data not shown]).  Taken together, 
these data show a complex interplay between the Ube3a-AS and Ube3a gene expression, 
suggesting the imprint may in fact regulate dosage of Ube3a in neurons.  
  
 
Figure 15.  Pharmacological inhibition of the Ube3a-AS doubles Ube3a protein levels in neurons.  A) 
Immunofluorescent images of primary cortical neurons derived from Ube3a
+/+
 mice and
  
Ube3a
+/+
 
neurons treated with topotecan.  Map2, microtubule associated protein 2; TO-PRO-3 Iodide nuclear stain.  
Scale bar, 10m.  B) Relative Ube3a expression in primary neurons with Ube3a+/+ set equal to 1.  n = 37 
Ube3a
+/+
, 38 Ube3a
+/+
  topotecan.  *** P < 0.001. 
 
4.6 Biallelic Expression of the Opossum UBE3A Gene Does Not Correlate with 
Increased UBE3A Protein Levels 
Our observations of increased maternal-allelic expression during the acquisition of the 
imprint in neurons and elevated Ube3a protein levels in the brain suggested the imprint  
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did not evolve to negatively regulate Ube3a in neurons; however, the two-fold increase 
of Ube3a in neurons expressing both parental alleles implied the imprint may in fact 
have evolved to negatively regulate Ube3a. Therefore, we tested the hypothesis that the 
evolutionary acquisition of the UBE3A imprint correlated with decreased UBE3A 
Figure 16.  The mouse, human, and opossum Ube3a/UBE3A protein sequences are highly conserved. 
A) Alignment of Ube3a orthologs among human, mouse, and opossum.  “*”, match. “:”, conserved amino
acid (AA) substitution.  “.” semi-conserved AA substitution. “ “, non-conserved AA substitution or 
insertion/deletion. “_”, call not made because of mismatch between all three species of varying 
conservation. B) Summary of amino acid mismatches and percent identity between species. 
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protein levels in the brain. As an evolutionary outlier, we used the gray, short-tailed 
opossum (Monodelphis domestica), a metatherian mammal lacking an orthologous 
region of the human 15q11-13 imprinted region. The opossum UBE3A protein sequence 
is highly similar (36-56/870; 93-95% [Figure 16]) to the mouse and human 
UBE3A/Ube3a protein sequences and thus considered a suitable evolutionary outlier for 
this study.  Furthermore, UBE3A is biallelically expressed in marsupials [105].  We 
examined UBE3A steady state protein levels in the cortex, hippocampus, heart, and 
lung.  Similar to the mouse (Figure 7B), UBE3A protein levels were elevated in the 
opossum brain relative to the peripheral organs (P = 0.001 [Figure 17A]).  Direct 
comparisons between UBE3A/Ube3a protein levels in opossum and mouse brain, 
however, revealed a 1.7 fold increase of Ube3a in the mouse brain relative to the 
opossum brain (P = 0.008 [Figure 17B]).  To account for possible discrepancies in the 
affinity of the UBE3A antibody between the two species, we compared the relative 
ratios of UBE3A/Ube3a protein among brain and peripheral organs.  The ratio of Ube3a 
protein in the mouse brain was greater than the opossum brain (Figure 17C), suggesting 
that the imprinted expression of Ube3a in the mouse brain produces more Ube3a protein 
than biallelic expression in the opossum brain.  Collectively, these data suggest that the 
UBE3A imprint did not evolve to negatively regulate UBE3A protein levels in the brain. 
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Figure 17.  UBE3A allelic transcript levels in brain and UBE3A protein levels in brain and 
peripheral tissues of opossum compared to mouse.  A) Normalized UBE3A protein levels isolated from 
wild-type opossum tissues.  Levels are shown as a ratio of expression in tissues relative to heart, 
normalized by Ponceau total protein stain. n = 4.  *** P < 0.001. Ct, cortex; Hp, hippocampus; Ht, heart; 
Lg, lung.   B) Normalized Ube3a/UBE3A protein levels isolated from wild-type mouse and opossum 
cortex.  Levels are set to average UBE3A = 1, normalized by Ponceau total protein stain. n = 4. .** P < 
0.01.  C) Ratio of average Ube3a/UBE3A expression in brain relative to peripheral tissues in mouse and 
opossum. 
4.7 The Ube3a-Snrpn snoRNA Clusters Are Functionally Coupled to the 
Ube3a-AS 
4.7.1 The Mouse Ube3a-Snrpn snoRNAs Evolved from Snord119 
Given evolutionary constraint of the Ube3a imprint in neurons and the absence of any 
evidence indicating that it functions to negatively regulate Ube3a protein levels, we then 
hypothesized that the Ube3a-AS may in fact be under selection and functional. To 
determine a functional link between the Ube3a-Snrpn snoRNAs and the Ube3a-AS, we 
first examined the evolutionary history of the snoRNA genes/clusters: Snord107 (1 
copy), Snord64 (1 copy), Snord116 (27 copies, 10 unique), and Snord115 (136 copies, 
56 unique) (Appendix D).  Alignment of the snoRNAs revealed that each contained 
A   B  C 
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canonical C, D, C`, and D` boxes (Figure 18A).   Phylogenetic analysis of the mouse 
snoRNAs, their human orthologs, and the Snord119 gene (mouse, human, and opossum) 
indicated that the snoRNAs in the region originated from Snord119 [140] (Figure 18B).  
This is consistent with the evolutionary history of the orthologous cluster in humans 
(Figure 18B and Appendix E [12]).  The evolutionary history also appeared to correlate 
with their organization along the chromosome (5`-Snrpn to 3`-Ube3a [Appendix E]). 
Figure 18.  The human 15q11-q13 and mouse 7C SNORD/Snord gene clusters arose from Snord119.  
A) Representative sequence alignments of mouse (m) and human (h) SNORDs - 64,  107, 115, and 116 -
to the ancestral sequence, SNORD119, from mouse, human, and opossum (o).  Consensus sequence was 
extracted based on base conversation (red shading is high and blue shading is low) between all sequences. 
Sequence logo displays all bases represented at each position, stacked vertically with their heights 
representing relative base frequency: A = adenine, red; T = thymine, green; C = cytosine, blue; and, G = 
guanine, gold.  Conserved characteristic C/D box snoRNA sequences are underlined C, D’, C’, D.  B)  
Schematic representation of tree clustering analysis of all human and mouse SNORD sequences 
(Appendix E).  Horizontal distance is representative of relative sequence divergence from branch points. 
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The presence of identical/high percent identity Snord115 and Snord116 gene copies and 
the lack eutherian conservation at the host-gene exons (Appendix F) and intervening 
sequences suggested the snoRNAs have been under selection and, perhaps, 
homogenized. 
4.7.2 The Snurf-Snrpn, snoRNA host-genes/snoRNAs and Ube3a-AS RNAs Are 
Likely Transcribed as a Single Polycistronic Transcript 
We next analyzed ChIP-seq and RNA-seq data (described above) to examine whether 
the Snurf-Snrpn, Snord gene clusters, and Ube3a-AS transcripts were assembled into a 
single or multiple individual transcript(s). Consistent with prior studies, we did not 
detect features (e.g., trimethylated histone 3 lysine 4, acetylated histone 3 lysine 9, and 
RNA polymerase II enriched regions) 3` of Snurf-Snrpn that were consistent 
independent promoter being used to transcribe the snoRNAs and Ube3a-AS, further 
supporting the notion that the genes in the Snrpn-Ube3a region are transcribed as an 
single unit (APPENDIX G [12, 27]). 
4.7.3 The Snurf-Snrpn, snoRNA host-gene Exons, and Ube3a-AS Exhibit Brain-
Specific Alternative Splicing Events and Polyadenylation Patterns 
Analysis of the RNA-seq data revealed extensive alternative splicing (canonical 5`-GT-
AG-3`) of the Snurf-Snrpn coding and upstream untranslated region (UTR) exons in the 
brain; however, there were no spliced transcripts detected between Snurf-Snrpn and the 
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downstream Snord64 host-gene exons (APPENDIX H-I).  We did detect spliced 
transcripts among the Snord116 host-gene exons and Ipw and between the 3` exon of 
Ipw and a single 5 ` Snord115 host-gene exon (APPENDIX J-L).  At the 3` end of the 
Snord115 cluster, we also detected spliced transcripts between the Snord115 host-gene 
exons and the 5` end of the Ube3a-AS (Figure 19  and APPENDIX M).   In the Ube3a-
AS, we detected numerous splicing events, including a single continuous transcript of 7 
exons that extended from the 3` end of the Snord115 cluster to a region approximately 
30 kb 5` of the Ube3a transcriptional start-site (TSS).  Most of the Ube3a-AS exons were 
alternatively spliced and, except for one 5` - 3` splice event in Ube3a exon 6, primarily 
located in intronic regions at the 3` end of Ube3a (Figure 19 and APPENDIX N).  
Analysis of strand-specific polyA-seq data identified numerous brain specific 
polyadenylation (polyA) signals in the Ube3a-Snrpn region (Figure 19 and APPENDIX 
H-O).  Most of the brain-specific polyAs were present on the minus strand and thus 
represented polyA tails of RNAs transcribed in the same orientation as the Snurf-Snrpn, 
snoRNA, and Ube3a-AS RNA transcripts.   There were numerous polyAs located within 
the Snord116 cluster (minus strand) and one polyA located at the 5` end of the Snord115 
cluster (minus strand).  The remaining brain-specific polyAs were located in Ube3a 
introns 4 (plus and minus strand) and 11 (minus strand), the Ube3a TSS (minus strand), 
and a region 5` of the Ube3a TSS.  The polyAs located upstream of Ube3a were 
immediately 3` of the distal Ube3a-AS exon (APPENDIX M-O).  Collectively, these 
data suggest polyadenylation decouples the Snurf-Snrpn and Snord host-gene transcripts 
(i.e., Snord64, Snord116 and Snord115) and splicing excises functional snoRNA species 
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Figure 19.  Alternative splicing patterns of Ube3a and the Ube3aAS.  The schematic diagrams depicts alternative splicing patterns detected in brain 
and heart by RNAseq and RT-PCR on the maternal (M) and paternal (P) alleles.  Numbers represent exons of Ube3a.  Line composition differentiates 
tissue specificity of splicing and line color differentiates allelic specificity.  Lines above gene depictions represent 5’  3’ splicing from left to right on 
the plus strand of DNA and lines below the genes reflect 5’  3’ splicing from right to left on the minus strand of DNA.  Orange bars represent strand 
specific polyadenylation sites (APPENDIX X), their heights are proportional signal strength by RNAseq, and bars above the line are specific to the plus 
strand and bars below the line are specific to the minus strand.  Schematic is not to scale but spans approximately 170 kilobases (kb) and the hash marks 
represent a gap of approximately 21kb
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in the brain.  The Snord115 host-gene exon(s), however, are coupled to the Ube3a-AS, 
which is processed into multiple alternatively spliced, polyadenylated transcripts, 
suggesting it has additional functions aside from silencing Ube3a paternal-allelic 
expression in neurons. 
4.8 The Ube3a Gene Is Extensively Alternatively Spliced in the Brain 
Analysis of the RNA-seq data also confirmed the expression in both the brain and heart 
of the known Ube3a transcript variants representing transcript variants 1 and 3, which 
are not distinguishable at the 5` exons, and transcript variant 2.  In the brain, we also 
detected a novel transcript that spliced from exon 4 to a region in intron 4, which was 
located 5` of the brain-specific polyA signals described above (plus strand) (Figure 19 
and APPENDIX N-O).  Although we were unable to determine the parent of origin of 
this novel transcript, prior studies have shown that the paternal Ube3a allele transcribes 
a 5` truncated transcript that terminates in intron 4 [20, 31].     
We next used RT-PCR to confirm the Ube3a transcript variants and identify additional 
transcripts that were undetectable in the RNA-seq data.  Using combinations of primers 
specific to each Ube3a exon (APPENDIX P), we confirmed the presence of the known 
Ube3a splice variants (sense and antisense) and the novel 5` truncated transcript.  The 
RT-PCR also showed that the Ube3a transcript variant 1/3 was the most abundant 
transcript in the brain.  We also detected novel alternatively spliced transcripts that 
reflected splicing events between exons 1 and 3 and between exons 4 and 7 in both brain 
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and heart. The 1-3 splice event preserves the Kozak consensus sequence and start site of 
Ube3a transcript variant 2.  The 4-7 splice event lacked the translational start codon of 
transcript variants 1/3; however, the 5` end of the transcript contained the 5` UTRs 
associated with transcript variant 1/3 and a novel Kozak consensus sequence preceding 
an in frame methionine.  This variant was more abundant in heart than in brain, and, if 
translated, would produce a truncated protein containing the HECT domain 
(APPENDIX P).  Both novel splicing events were confirmed by Sanger sequencing. 
Since the novel 4-7 splice variant was predicted to skip the exon deleted (exon 5) in the 
Ube3a knockout mouse model, we next used a TaqMan RT-PCR assay to analyze brain- 
and heart-RNA (mRNA and toRNA) isolated from wild-type and Ube3a maternal- and 
paternal-deficient mice (Ube3a
+/+
, Ube3a
-/+
, Ube3a
+/-)
.  In the heart samples of both
Ube3a
+/-
 and Ube3a
-/+
 mice, there was approximately a 50% reduction in toRNA and
mRNA, which was anticipated.  Analysis of the cortical samples, however, revealed 
relatively equal amounts of toRNA and mRNA among all three genotypes, suggesting 
the presence of either a novel promoter or an unknown splicing pattern not involving 
exon 5.  Additional RT-PCR analyses in each genotype confirmed the presence of the 4-
7 splice variant.  A novel splice variant between exons 4 and 6 was also detected, but the 
transcript variant was only detected in samples isolated from the Ube3a
-/+
 and Ube3a
+/- 
mice, suggesting it was an atypical splicing event (APPENDIX P).  
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Visual examination of the RNA-seq data revealed that there was a disproportionate 
number of reads aligning to the Ube3a introns in the brain relative to the heart.  
Genome-wide analysis of exon/intron read-depth ratios revealed the brain samples had 
increased intronic read-depth ratios (Wilcoxon signed rank-test), suggesting the reads 
reflected an abundance of immature RNA transcripts in the brain relative to the heart.  
Further analysis of informative variants in the intronic reads revealed that most were 
derived from the paternal Ube3a allele but some reflected maternal-allelic expression.  
We also observed a “saw-tooth” pattern of read-depth ratios across some of the introns, 
particularly intron 4, suggesting increased levels of alternative splicing events involving 
the flanking exons in the brain, which was consistent with the number of alternatively 
spliced Ube3a sense and antisense transcripts identified in the brain (Figure 20 and 
APPENDIX P) [141]. 
Collectively, these data demonstrate the existence of novel alternatively spliced Ube3a 
transcript variants (heart and brain), which are also expressed in the Ube3a knockout 
mouse model. Furthermore, these data show that different rates of Ube3a RNA 
processing between the heart and brain, which likely reflects different patterns of 
alternative splicing events between the two tissues. 
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Figure 20.  RNAseq coverage of informative allelic single nucleotide polymorphisms across Ube3a in the brain.  Image depicts the relative coverage of maternal (pink bars) and paternal (blue bars) of allelic single 
nucleotide polymorphisms (SNPs) across the introns of Ube3a.  The positive slope of predominately paternal SNPs suggests transcription of the minus strand consistent with Ube3a-AS expression.  Enrichment of these 
same SNPs flanking exons suggests alternative splicing at these sites.  Orange bars represent relative intensity of strand specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red arcs represent 
canonical “GT-AG” splicing events in the 5’  3’ direction of the plus strand.  Blue arcs represent canonical “GT-AG” splicing events in the 5’  3’ direction of the minus strand.
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5. CONCLUSIONS
Loss-of-function or dysregulated expression of UBE3A in the brain has devastating 
consequences, which strongly suggest that UBE3A is a dosage sensitive gene.  It is thus 
perplexing that the UBE3A gene is imprinted in neurons where it is critically important; 
unless, the imprint evolved as an important mechanism to regulate the UBE3A 
expression levels in neurons.  Indeed a gene dosage/gene expression model has been 
proposed to explain the evolution of genomic imprinting at some loci [142, 143]. Most 
studies to date involving UBE3A have focused on what function UBE3A has in neurons; 
few studies, if any, have addressed why UBE3A is imprinted in neurons. In this 
dissertation, it was hypothesized that genomic imprinting of UBE3A evolved as a 
mechanisms to negatively regulate UBE3A levels in neurons.  The data presented here, 
however, rejects this hypothesis.  Based on our findings, we propose a novel hypothesis 
in which the imprint evolved to facilitate neuron specific co-expression of the UBE3A 
and SNORD115-SNORD116 genes and, perhaps, regulate the expression of neuron 
specific UBE3A isoforms.  Although further studies are necessary to confirm this 
hypothesis, the findings presented here significantly advance our understanding of why 
UBE3A is specifically imprinted in neurons. 
We show a non-linear relationship between the number of active Ube3a alleles and the 
amount of total Ube3a protein produced in the cell (Figure 21).  Independent of the 
number of expressed alleles, the Ube3a gene is expressed at higher levels in neurons of 
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Figure 21.  The number of active functional alleles of Ube3a does not correlate with expression levels 
in neuron compared to non-imprinted cell types.  Ube3a is biallelically expressed in neural stem cells 
(NSCs) (colored right angle arrows, 1x).  Upon differentiation (black arrows) NSCs give rise to astrocytes 
and neurons.  Astrocytes biallelically express Ube3a and do not appear to change total protein levels from 
NSCs.  Conversely neurons express only the maternal allele, yet total Ube3a levels increase during the 
course of differentiation.  This leads to increased maternal expression, but relatively constant expression of 
Ube3a in developing neurons (2x maternal 2.3x total).  Furthermore this unexpected expression pattern of 
maternal Ube3a coincides with expression of the paternal Ube3a-AS which is expressed across the length 
of Ube3a and exhibits alternative splicing (dashed blue arrow).  This suggests that the Ube3a imprint did 
not evolve strictly to regulate Ube3a dosage.  Angled arrow heights reflect relative levels of expression.  
Pink = maternal and Blue = paternal. 
appears to be evolutionarily conserved. The preservation of this phenomenon supports 
current beliefs that Ube3a plays a critical role in neural function and synapse formation 
[129-136]. Interestingly, although increased expression of Ube3a in neurons is 
conserved between mouse and opossum, its total dosage does not appear to be similarly 
restricted.  This is further complicated by the knowledge that, at least in humans, the 
expression of UBE3A is tightly regulated.  This suggests that although total 
Ube3a/UBE3A protein levels have some critical level in the cell, the levels may be 
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dictated to some degree by the expression of Ube3a/UBE3A relative to other genes in the 
cell, possibly one of its theorized targets or cofactors discussed previously. 
The observations of increased maternal-allelic expression during neurogenesis and the 
inability of Ube3a to negatively regulate biallelic expression in neurons suggest that an 
independent mechanism evolved to compensate for the loss of paternal-allelic expression 
in neurons.  This postulation is supported if we simultaneously consider the evolution of 
the Ube3a-Snrpn region as it exists in placental mammals.  The formation of the locus 
was due to a chance rearrangement that was most likely not immediately detrimental to 
the fitness of the organism; however, the ability of some individuals/organisms to regain 
a level of Ube3a expression consistent with levels that existed previous to the imprint 
provided some sort of competitive benefit.  Once this was accomplished through the 
establishment of the imprint, the need for autoregulation of the gene product was no 
longer needed as over expression of the gene product was highly unlikely secondary to 
the selective pressures preserving the imprint and expression of paternal genes to overall 
organism fitness (see below) and under expression of the gene would likely result in 
offspring that would not be fit to reproduce. 
Our observations that Snurf-Snrpn, the Snord snoRNA gene clusters, and the Ube3a-AS 
are expressed as a single polycistronic transcript and that the Ube3a-AS is 
transcriptionally coupled to the Snord115 host-gene exons and processed suggests that 
the Ube3a-AS is either a functional component of the Snord115 locus, functions as an 
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independent RNA, or a protein-coding transcript.  Previous studies have shown that the 
Snord115 host gene exons form an RNA cloud that is restricted to the Ube3a-Snrpn 
locus[116, 117].  The transcriptional link that we demonstrate between the Ube3a-AS 
and the Snord115 host-gene transcript suggests that the Ube3a-AS functions as the 
anchor for the localization of the RNA cloud.  This would be supported by the extensive 
coverage of the Ube3a introns seen exclusively from the paternal allele.  Alternatively, 
the Ube3a-AS could simply act as a 3’ UTR for Snord115. Future studies involving the 
analysis of the Snord115 host gene RNA cloud would need to be done using a Ube3a-AS 
knockout model or in cells treated with topotecan in order to define the fundamental role 
of the Ube3a-AS.  The idea that the Ube3a-AS has an independent function is supported 
in the study reported by Meng et al. (2014) [18].   Insertion of a termination signal in the 
3` UTR of Ube3a (Ube3a-ATS knockout mouse [KO]) partially reactivates Ube3a 
paternal-allelic expression in the brain and improves, but does not fully restore, the 
neurological deficits observed in the AS mouse model (Ube3a
-/+
).   The authors also
showed increased expression of the imprinted Necdin gene, which is located in the 7c 
imprinted region but approximately 3000 kb downstream of Ube3a.  Although the 
relationship between the Ube3a-AS and Necdin is unclear, it is tempting to speculate that 
the Ube3a-AS, or an imprint dependent Ube3a isoform negatively regulates Necdin 
expression in the brain.    Finally, based on current data, we cannot exclude the 
possibility that some component(s) of the Ube3a-AS transcript may contain protein 
coding sequences.  The extent of alternative isoforms predicted in our study made full 
evaluation of this possibility prohibitive.  Furthermore, recent discoveries of small 
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protein coding genes (e.g., less than 40 amino acids) prove the existence of small open 
reading frames, which were previously believed to be non-functional [144-146].  
Nevertheless, our findings support the notion that the imprint did not simply evolve as a 
mechanism to down-regulate the level of UBE3A in neurons.  
Based on our findings, we propose that genomic imprinting of SNURF-SNRPN-
SNORDs-UBE3A-AS and UBE3A evolved to allow co-expression of these genes in 
neurons.  This idea is consistent with the Complementation Hypothesis proposed by 
Kaneko-Ishin et al. [147].  In the Complementation Model, genomic imprinting evolved 
as a mechanism to maintain the expression of at least one allele of two genes that 
compete for transcriptional elements/resources.  The genes may be functionally linked or 
not; however, they do rely on the same genetic elements to allow or regulate expression 
of their respective genes.  In this model, biallelic expression of one gene (e.g., Gene-A) 
outcompetes another gene (Gene-B) for elements that both require for transcription; as a 
result, Gene-B is inactivated on both alleles.  Genomic imprinting of the regulatory 
element in one parental germ-line (i.e., the creation of a differentially methylated region 
or imprinting control element) would inhibit the expression of Gene-A on the allele 
carrying the germ-line modification.  As a result, Gene-B would be expressed on this 
chromosome.  Indeed, expression of Snurf-Snrpn, Snord snoRNAs, and Ube3a-AS is 
negatively regulated by the methylation of the PWC-ICE on the maternal chromosome 
[148].  Loss of the paternal methylation at the PWS-ICE results in biallelic expression of 
the polycistronic transcript and repression of both parental Ube3a alleles.  There is no 
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known phenotype associated with biallelic expression of the polycistronic transcript as 
paternal uniparental disomy results in Angelman syndrome, not a unique disease; 
however, decreased or increased Ube3a expression is detrimental.  Thus, loss of 
expression of the polycistronic transcript on the maternal chromosome via genomic 
imprinting protects the maternal Ube3a allele from being silenced. Based on our 
observations, we propose that the Complementation Model likely drove the evolution of 
imprinting of 15q11-q13 and the orthologous regions in other placental mammals. If 
expression of the Ube3a-AS also gives rise to imprint dependent transcripts of Ube3a or 
itself (e.g., through alternative splicing events), there may be other advantages resulting 
from the creation of an imprinted region, as seen at the GNAS locus.  Further studies are 
necessary to demonstrate that the Ube3a-AS expands the repertoire of functionally 
meaningful Ube3a isoforms. 
Furthermore, our understanding of the diseases associated with 15q11-q13 support that 
the imprint evolved to allow co-expression UBE3A and the SNORD115-SNORD116 
genes.  Many attempts to produce Prader-Willi mouse models failed because loss of 
paternal expression in this region led to failure to thrive, poor suckling, and soft palate 
defects, leading to neonatal mortality [149].  Conversely, maternal inheritance of these 
same defects showed no such phenotype.  This and other observations suggest the 
existence of evolutionary constraint acting on the paternally expressed transcripts in the 
region.  Furthermore, phenotypes observed in Angelman syndrome show only minimal 
correlation with genetic cause.  In fact genetic changes leading to functional duplication 
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of paternally expressed genes (imprinting defects or paternal uniparental disomy) have a 
less severe phenotype [40, 121, 122].  Therefore, these paternally expressed transcripts 
are not overtly dosage sensitive, but their expression is essential for life. 
Previous studies indicate equal allelic expression of the 5’ end of Ube3a in the brain [20, 
31].  We detected a novel exon at the end of the region predicted to be biallelically 
expressed.  This exon is upstream of a polyadenylation signal and detected by cDNA 
PCR in only Ube3a
-/-
 mice.  This may have occurred secondary to primer dilution in
other animals because of the relative prevalence of major isoforms.  These findings do 
not explain the observation of equal toRNA and mRNA levels in the brains of Ube3a in 
Ube3a
+/- 
and Ube3a
-/+ 
mice; however, another report suggested the presence of Mef2
bound promoters within Ube3a that were distinct from the canonical Ube3a promoter 
[150].  One of these promoters is found downstream of the AS mouse deletion and 
coincides with predicted novel human protein isoforms arising from 3’ exons of Ube3a.  
Furthermore, the discovery of other unique transcripts demonstrated splicing around the 
AS mouse deletion, which may also be contributing to the RNA findings. 
The post-transcriptional processing and the extent of transcription across Ube3a of the 
Ube3a-AS shown here is novel.  It further highlights the complexity of the Ube3a-AS 
transcript and demonstrates that it does not simply function to down-regulate expression 
of Ube3a.  This data suggests that previous quantifications and investigation of the 
Ube3a-AS may have been misleading as they would be synonymous to measuring a 
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coding transcripts’ steady state levels by measuring the presence of its introns.  We do 
however, note significant coverage of the introns of Ube3a almost exclusively from the 
paternal allele, which we presume to be the antisense transcript, suggesting some 
increased stability or alternate functionality of the unspliced portions of the antisense 
overlapping Ube3a compared to the unspliced portions of the maternal sense Ube3a 
transcript.  The idea of increased stability is supported by the existence of the Snord115 
host gene cloud that localizes to the locus [116, 117].  Furthermore, alternative 
functionality cannot be excluded in the face of the ever expanding discovery of novel 
RNA forms.  Although searches for sequence and structure homology failed to reveal 
functional RNA motifs in the Ube3a-AS introns, the possibility still exists for yet 
unidentified or unannotated RNA structures imbedded in these transcripts. 
 
The importance of appropriate Ube3a expression in the brain is unequivocal; however, 
the importance of the various Ube3a isoforms is incompletely understood.  We identified 
two additional Ube3a transcript variants.  Although their functions are unknown, they 
both contain open reading frames that would generate smaller Ube3a proteins with a 
functional HECT domain.  The characterization of these novel isoforms requires further 
analysis. It is possible that these variants may be directed to specific areas of the cell 
based on their 5` sequence or have differing target specificities based on amino acid 
changes outside of the HECT domain. 
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The approach of alternative transcript identification used here is limited.  This approach 
is restricted to identifying alternative splice transcripts, but is unable to detect truncated 
transcripts or transcripts using previously unidentified upstream or downstream coding 
or non-coding exons.  These pitfalls do not mitigate the findings presented here but do 
require appreciation of other transcriptional possibilities.  Furthermore, the 
transcriptional activity of the Ube3a
+/-
 mice and the relative paucity of coding SNPs
identified in hybrid mice prohibited investigation of allele specific transcript variants. 
Angelman syndrome, chromosome 15q11-q13 duplication syndrome, and Prader-Will 
syndrome have overlapping phenotypes of intellectual disability, social communication 
deficits (e.g., autism spectrum disorder), and motor developmental delay/impairment. 
Given that these syndromes arise from dysregulation of transcriptionally coupled genes 
located in the 15q11-q13 imprinted region, understanding their cellular roles in the brain 
and the manner in which they are functionally linked is not only important to understand 
the pathogenesis and management of these syndromes, but to other neurodevelopmental 
conditions with overlapping features as well.  The findings presented here shed light on 
the function of the UBE3A imprint, refine our knowledge of Ube3a expression, provide 
novel data on the complex structure and post-transcriptional processing of the SNURF-
SNRPN-SNORDs-UBE3A-AS polycistronic transcript, suggest the existence of 
previously unappreciated Ube3a isoforms, and provide a foundation for future studies.  
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APPENDIX A 
APPENDIX A. The mouse 7C imprinted region is upregulated in the heart.  Graph of normalized allelic expression for all RefSeq annotated Genes in the mouse 7C region in brain and heart from RNA-seq 
analysis.  Genes are presented in genetic order by start position. Only unambiguous SNVs in exons and 3’ untranslated regions were used for ratios.  Gray bars indicate the absence of informative coding SNVs for that 
gene. n = 6.  Significance values are indicated on gene names representing comparisons between tissues, * P < 0.05, ** P < 0.01, *** P < 0.001
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APPENDIX B 
Please see attached Microsoft Excel file entitled “APPENDIX”, sheet “APPENDIX B”.  
This table summarizes the analysis of RNA-seq data for all genes in the 7c region.  This 
table contains 37 columns detailing gene coordinates and sizes, per animal and averaged 
expression values, significance tests, fold change calculations by two alternative 
methods, informative coding single nucleotide polymorphism (SNP) counts and allelic 
contributions, and calculated allelic expression values. 
APPENDIX B 
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APPENDIX C 
Please see attached Microsoft Excel file entitled “APPENDIX”, sheet “APPENDIX C”.  
This table summarizes all single nucleotide polymorphisms called amongst all 6 mice in 
the 7c region for both brain and heart and details the total coverage and allelic frequency 
of each polymorphism. 
APPENDIX C 
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APPENDIX D 
Please see attached Microsoft Excel file entitled “APPENDIX”, sheet “APPENDIX D”.  
This table summarizes all the snoRNAs found in the Ube3a-Snrpn region.  Ensembl 
annotations and genomic coordinates were used to extract sequences.  Assigned naming 
was based on duplication frequency and location on the chromosome in the order of 
transcription. 
APPENDIX D 
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APPENDIX E 
APPENDIX E.  Human and mouse snoRNAs derive from the same ancestral snoRNA, SNORD119.   Tree clustering analysis of all human (h) and 
mouse (m) Snrpn-Ube3a region SNORD sequence, rooted from ancestral human, mouse, and opossum (o) SNORD119.   Horizontal distance is 
representative of relative sequence divergence from branch points 
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APPENDIX F 
APPENDIX F.  Snord host-gene exons do not reflect the same evolutionary conservation as their resident snoRNAs.  Alignment of all junctional exons extracted 
from RNA-seq splicing events within the Ube3a-Snrpn intergenic region.  No alignment or elements of conservation were detected amongst these exons. 
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APPENDIX G 
APPENDIX G.  Analysis of Ube3a-Snrpn intergenic region Chip-Seq data does not indicate the presence of marks 
consistent with promoters.  Screen capture of UCSC genome browser with RefSeq annotations.  Top row of peaks represent 
trimethylated histone 3 lysine 4 RNA-seq read alignments in adult mouse whole brain.  Bottom row of peaks represent RNA 
polymerase II (Pol2) RNA-seq read alignments in adult mouse whole brain.  Note the enrichment of both elements over the 
promoters of both Ube3a and Snrpn and the absence of any such enrichment in the intergenic region. 
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APPENDIX H 
APPENDIX H.  The upstream exons of the Snurf-Snrpn exhibit extensive alternative splicing in the brain.  Illustration of alternative splicing 
events and strand specific polyadenylation sites in the Snurf-Snrpn upstream region.  Top track line represents previously described alternative upstream 
exons of Snurf-Snrpn (“U” exons) [25].  RefSeq gene annotations are represented and labeled in blue.  Orange bars represent relative intensity of strand 
specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red arcs represent canonical “GT-AG” splicing events in the 5’  3’ direction of 
the plus strand.  Blue arcs represent canonical “GT-AG” splicing events in the 5’  3’ direction of the minus strand.
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APPENDIX I 
APPENDIX I.  Alternative splicing flanking Snord64 is not contiguous with Snurf-Snrpn.  Illustration of alternative splicing events flanking Snord64.  Alternative splicing events 
surrounding Snord64 are contiguous with downstream splicing around Snord116 but not with upstream splicing of Snurf-Snrpn.  RefSeq gene annotations are represented and labeled in blue. 
Orange bars represent relative intensity of strand specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red arcs represent canonical “GT-AG” splicing events in the 5’  3’ 
direction of the plus strand.  Blue arcs represent canonical “GT-AG” splicing events in the 5’  3’ direction of the minus strand. 
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APPENDIX J 
APPENDIX J.  Snord116 host gene exons demonstrate alternative splicing and are linked with Snord64 and Ipw.  Illustration of alternative splicing events within the Snord116 cluster. 
Alternative splicing within Snord116 link it to Snord64 upstream and Ipw downstream.  RefSeq gene annotations are represented and labeled in blue.  Orange bars represent relative intensity 
of strand specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red arcs represent canonical “GT-AG” splicing events in the 5’  3’ direction of the plus strand.  Blue arcs 
represent canonical “GT-AG” splicing events in the 5’  3’ direction of the minus strand. 
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APPENDIX K 
APPENDIX K.  The Snord116 clusters splice into Ipw and around strand specific polyadenylation signals.  Illustration of 
alternative splicing events of Snord116 into Ipw.  Alternative splicing of Snord116 into Ipw leads to splicing around strand 
specific polyadenylation signals.  RefSeq gene annotations are represented and labeled in blue.  Orange bars represent relative 
intensity of strand specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red arcs represent canonical “GT-
AG” splicing events in the 5’  3’ direction of the plus strand.  Blue arcs represent canonical “GT-AG” splicing events in the 
5’  3’ direction of the minus strand. 
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APPENDIX L 
APPENDIX L.  The Snord116 clusters and Ipw transcripts are contiguous with the Snord115 cluster.  Illustration of 
alternative splicing events within Ipw.  Alternative splicing of Snord116 and Ipw link these transcripts with the 5’ end of the 
Snord115 cluster.  RefSeq gene annotations are represented and labeled in blue.  Orange bars represent relative intensity of 
strand specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red arcs represent canonical “GT-AG” splicing 
events in the 5’  3’ direction of the plus strand.  Blue arcs represent canonical “GT-AG” splicing events in the 5’  3’ 
direction of the minus strand. 
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APPENDIX M 
APPENDIX M.  The Snord115 cluster demonstrates alternative splicing into the 3’ end of Ube3a.  Illustration of 
alternative splicing events between Snord115, Ube3a-AS, and Ube3a.  Alternative splicing of the 3’ end of Snord115 is 
contiguous with Ube3a-AS and overlaps the 3’ end of Ube3a.  RefSeq gene annotations are represented and labeled in blue.  
Orange bars represent relative intensity of strand specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red 
arcs represent canonical “GT-AG” splicing events in the 5’  3’ direction of the plus strand.  Blue arcs represent canonical 
“GT-AG” splicing events in the 5’  3’ direction of the minus strand. 
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APPENDIX N 
APPENDIX N.  Both Ube3a and Ube3a-AS show extensive alternative splicing in the brain.  Illustration of alternative 
splicing events across Ube3a.  Alternative splicing of Ube3a reveals novel alternative transcripts at its 5’ end.  These novel 
transcripts appear to terminate in regions consistent with strand specific polyadenylation signals (orange bars).  The Ube3a-AS 
shows even greater alternative splicing into and within Ube3a.  These splice site are into and out of both introns and exons of 
Ube3a.  Furthermore, these transcripts also terminate at strand specific polyadenylation signals within and upstream of Ube3a. 
Orange bars represent relative intensity of strand specific (plus strand, top; minus strand bottom) polyadenylation sites.  Red 
arcs represent canonical “GT-AG” splicing events in the 5’  3’ direction of the plus strand.  Blue arcs represent canonical 
“GT-AG” splicing events in the 5’  3’ direction of the minus strand. 
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APPENDIX O 
APPENDIX O 
Please see attached Microsoft Excel file entitled “APPENDIX”, sheet “APPENDIX N”.  
This table summarizes the location and relative strength of strand specific 
polyadenylation signals identified by RNA-seq, provided by the UCSC genome browser. 
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APPENDIX P 
APPENDIX P.  Confirmation and discovery of novel Ube3a transcripts in Ube3a+/+, Ube3a-/+, and Ube3a+/- mice.  A-D) RT-PCR amplification 
products of PolyDT cDNA using exon specific primers indicated above images (as described in Appendix Q).  Numbers to left of indicate size of ladder 
standard bands in basepairs.  Products column indicates measured product size in base pairs (bp) and predicted exon composition based on size, primers 
used, and subsequent sanger sequencing.  –RT; negative control of RT-PCR reaction run without reverse polymerase.  A) Confirmation of alternative 5’ 
splicing in both cortex (ctx) and hippocampus (hipp) of wildtype (m+ / p+) mice.  B-C) Identification of novel transcripts spanning the Ube3a+/- deletion 
in the cortex of wildtype (+) and maternal deficient, Ube3a-/+, mice (-).  
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APPENDIX Q.  Continued.  D)  Identification of novel transcripts spanning the Ube3a deletion in both 
the cortex and heart of wildtype Ube3a
+/+
 (m
+
/p
+
), paternal deficient Ube3a
+/-
 (m
+
/p
-
), and maternal 
deficient Ube3a
-/+
 (m
-
/p
+
) mice.    
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APPENDIX R.  Continued.  E)  Restriction enzyme digest of clones (bold bands at right of image) used 
in sanger sequencing (clones 1-3) for RT-PCR products amplified between exons 1 and 6 (1F_6R) (faint 
bands to left of image). F)  PCR amplification products from gel band excisions used in sanger sequencing 
(right side of image) from RT-PCR products amplified between exon 4 and 11 (4F_11R) (left side of 
image).   
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APPENDIX S.  Continued.  G)  Schematic representation of known Ube3a transcripts with 
representation of experimentally validated splicing events identified in preceding experiments. Vertical 
boxes represent individual exons, with coloration specific to contribution to the transcript as indicated in 
the key.  Lines indicate splicing events and connect exons that were shown to splice together, while line 
color and style refer to source of evidence as indicated in the key.  H-I) TaqMan analysis of total RNA in 
the brain (H) and heart (I) of Ube3a
+/+
, Ube3a
+/-
, and Ube3a
-/+
 mice.  J-K) Western blots and analysis of 
brain (J) and heart (K) of the same mice in H-I.  N = 6. * P < 0.05, ** P < 0.01, *** P < 0.001.  N.S. = not 
significant.    
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APPENDIX Q 
APPENDIX T 
Please see attached Microsoft Excel file entitled “APPENDIX”, sheet “APPENDIX Q”.  
This sheet contains genomic coordinates and sequences for all primers used in the 
reverse transcription assays. 
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APPENDIX R 
APPENDIX U 
Please see attached Microsoft Excel file entitled “APPENDIX”, sheet “APPENDIX R”.  
This table summarizes all antibodies used in immunofluorescence and western blotting 
with dilutions used and vendor information. 
